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Academy of Science(s): Academy of Science(s) refers to an assembly of intellectuals or 
fellowship of scientists dedicated to the advancement of scientific knowledge within their 
societies and on a global scale. A common feature of all the world’s science academies 
is to seek nationwide economic and social advancements through wise applications of 
science and technology (Network of African Science Academies, 2010).
Immunisation: The process whereby a person is made immune or resistant to an infectious 
disease, typically by the administration of a vaccine. Vaccines stimulate the body’s own 
immune system to protect the person against subsequent infection or disease (WHO, 2019) 
Vaccination coverage: The proportion of a targeted population immunised with the 
recommended schedule of vaccines (WHO, 2019).
Missed opportunities for vaccinations: Refers to any contact with health services by an 
individual who is eligible for vaccination (e.g.: unvaccinated or partially vaccinated and 
free of contra-indications to vaccination), which does not result in the individual receiving 
one or more of the vaccine doses for which he or she is eligible (WHO, 2019).
Under-immunisation: Refers to a state of sub-optimal protection against vaccine-
preventable diseases (O’Donnell, et al., 2017).  Sub-optimal levels of immunity result from 
not receiving all of the vaccinations scheduled for the specific age at which vaccination 
coverage is being measured. At the population level, under-immunisation results from sub-
optimal vaccination coverage, i.e.: vaccination coverage that is below the herd immunity 
threshold for any particular vaccine-preventable disease (VPD) (O’Donnell, et al., 2017).
Under-vaccinated children: An under-vaccinated child is any child missing one or more of 
the full series of recommended vaccinations  (WHO, 2009) 
Unvaccinated children: An unvaccinated child is defined as any child missing the 
recommended series of vaccinations. Diphtheria-pertussis-tetanus dose 3 vaccination 
coverage rates are used as a proxy of completion (WHO, 2009) 
Vaccine hesitancy: A delay in acceptance or refusal of vaccines despite availability of 
vaccination services. Vaccine hesitancy is complex and context specific varying across 
time, place, and vaccines. Vaccine hesitancy is influenced by factors such as complacency, 
convenience, and confidence  (WHO SAGE Working Group, 2014).
KEY DEFINITIONS
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Sub–Saharan Africa (SSA) alone accounts for 40% of all global deaths, a phenomenon 
attributed to lack of access to available lifesaving vaccines (Wiysonge, Uthman, Ndumbe, 
& Hussey, 2012). WHO estimates that in 2019 the African region accounted for approximately 
43% of unimmunised and incomplete immunised infants in the world (i.e.: 8.5 million of the 
global 19.4 million). Relatedly, the region scores the lowest immunisation coverage, at 76% 
versus the global coverage of 86%  (WHO, 2020a).
 
This is despite several documented efforts by different stakeholders to improve coverage 
in the region (Mihigo, Okeibunor, Anya, Mkanda, & Zawaira, 2017). Many studies have 
been conducted on coverage and drivers for and bottlenecks against immunisation in 
SSA.  (Wiysonge, Uthman, Ndumbe, & Hussey, 2012), (Wiysonge, Young, Kredo, McCaul, & 
Volmik, 2015), (Mihigo, Okeibunor, Anya, Mkanda, & Zawaira, 2017), (Madhi & Rees, 2018) 
(Bangura, et al., 2020), all of which have observed that there is varied performance among 
the constituent countries, and also within countries over time, denoting some implicitly 
common underlying correlates threading through areas of higher performance; and the 
same is seen with the poorer performing areas. 
This consensus study therefore seeks to categorise and make explicit these “root causes” and 
based on documented successes, to make recommendations to address the bottlenecks 
and harness the opportunities for reaching every child with all the recommended vaccines. 
The theory of change presentation style used in this report, categorising the root causes under 
four broad interlinked themes, can provide a common basis to rally like-minded partners 
around a thematic cause and thus develop multi-component, comprehensive strategies 
to bring about impactful change. This is in line with the call made by the World Health 
Organisation Strategic Advisory Group of Experts on Immunisation, which recommended 
that countries, regions and global immunisation partners commit to a comprehensive 
review of progress, impact, and implementation of the WHO Global Vaccine Action Plan to 
inform a post-2020 strategy taking into account lessons learned. This strategy will assist with 
attaining the relevant United Nations Sustainable Development Goals by 2030.
 
PROBLEM STATEMENT
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According	 to	 WHO,	 the	 Africa	 Region1 accounted for approximately 
43% of unimmunised and incompletely immunised infants in the world 
(8.5	 million	 of	 the	 global	 19.4	 million).	 Relatedly,	 the	 region	 had	 the	
lowest	 immunisation	coverage,	at	76%	versus	 the	global	coverage	of	
86% (WHO 2020a). 
This is despite several documented efforts to improve coverage in the region  (Mihigo, 
Okeibunor, Anya, Mkanda, & Zawaira, 2017). Whilst many academics and international 
organisations have interrogated the reasons for the region’s lower immunisation rates 
(Wiysonge, Uthman, Ndumbe, & Hussey, 2012), (Wiysonge, Young, Kredo, McCaul, & 
Volmik, 2015),  (Mihigo, Okeibunor, Anya, Mkanda, & Zawaira, 2017), (Madhi & Rees, 2018), 
(Bangura, et al., 2020), this study seeks to review the evidence for the underlying unique 
characteristics of sub-Saharan Africa (SSA) that are driving this low performance and find 
interventions that have been shown to work effectively at alleviating them.
In order to undertake this work, ASSAf, together with UNAS, followed a modified consensus 
study model,2 that allowed for the study experts to receive input and feedback from 
stakeholders. An eleven-member committee of trans-disciplinary experts was drawn from six 
SSA countries representative of  the different geographical and relevant expertise categories, 
and tasked to deliberate on the available scientific evidence (published and grey literature) 
and through constructive debate and agreement using the evidence reviewed, draw 
conclusions on the underlying drivers for low coverage and under-immunisation, as well as 
the proven interventions for improving immunisation coverage in SSA.
Evidence was compiled through a systematic literature search process that included two 
systematic reviews. In order to make sense of the evidence, the study organised the literature 
using a problem-based approach. Firstly, it sought to understand the vaccine coverage 
landscape with regards to the different vaccine characteristics. Three immunisation 
coverage indicators were used for this: diphtheria-tetanus-pertussis third dose (DTP3) as a 
proxy for a completely immunised child, measles-containing-vaccine second dose as a 
proxy for coverage of second year of life vaccines (MCV2), and rotavirus vaccine final dose 
as a proxy for coverage of newly introduced vaccines. Secondly, the study interrogated 
the evidence for the root causes of the regions’ sub-optimal immunisation coverage by 
considering demand-side and supply-side causes. In both cases, the study looked for 
common threads linking the various reasons given for low coverage and examined attributes 
of countries across the immunisation coverage continuum to identify commonalities that 
facilitated or hindered coverage improvement.  Based on the evidence, the committee 
made recommendations for priority actions to be undertaken by various immunisation 
stakeholders in order to reduce the number of un- and under-immunised children and 
achieve regional immunisation coverage targets.
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In reporting the findings and recommendations of the study, a Theory of Change (ToC) 
approach was used. This summarises the root causes of low coverage and under-immunisation 
in SSA under four inter-related, topical sub-themes: Knowledge, Trust, Convenience, and 
one crosscutting theme under-pinning all three, Political Ownership. 
The following is a summary of the study findings, conclusions and recommendations: 
Despite the global availability of efficacious and cost-effective vaccines, immunisation 
coverage in SSA is sub-optimal, as shown by the DTP3 regional coverage that has plateaued 
at 75% for the last five years. An immunisation grant programme by Gavi the Vaccine Alliance, 
has been pivotal in spurring introduction of new vaccines across the region, as evidenced 
by the ubiquitous introduction of rotavirus vaccine (37 of 48 countries introduced by 2019). 
However, uptake for vaccines administered in the second year of life is particularly dismal. 
Of the 29 countries that had introduced MCV2 by 2019, only three countries (Rwanda, 
Eritrea and Cape Verde) had achieved 90% coverage (GBD, 2019).
On a positive note, these observations of under-performance are not uniform across the 
countries in the region, nor across time. Some countries have stood out as having high 
immunisation coverage and some previously poorly performing countries have made 
significant improvements in the last ten years. This provides a point for peer examination 
and learning. Regarding the root causes of low coverage and under-immunisation in 
SSA and the strategies for addressing them, the following are the study conclusions and 
recommendations:
Knowledge – deficiencies and inaccuracies
Conclusions
1. Lack of knowledge regarding the benefits of immunisation, and the prevalence of 
misconceptions about vaccination effects among caregivers and community leaders, 
is one of the greatest root causes of low coverage and under-immunisation in SSA. 
2. This ignorance is commonly found in under-privileged community groups including 
younger mothers, illiterate and unschooled caregivers, people living in disadvantaged 
regions within a country, people with no history of contact with health facilities, migrant 
and refugee communities, among others.
3. Vaccine hesitancy is a growing trend in SSA driven by fears of side effects fueled by 
ignorance and false information circulated in the media, presenting a serious threat 
to efforts to increase immunisation coverage in the region. Region-specific studies on 
interventions against vaccine hesitancy are lacking.
4. Healthcare workers (HCW) are key resources for immunisation service provision as well as 
providers of accurate immunisation information for care givers and community leaders in 
their jurisdictions. However, the capacity of HCW to effectively deliver on these mandates 
is, in many instances, limited by their own knowledge deficiencies regarding vaccines 
and vaccine effects, immunisation policies, identification of un- and under-immunised 
children, social mobilisation and counselling skills, and data management. This limitation 
is attributed to a lack of adequate pre- and in-service training underpinned by limited 
political investment in this area.
5. Various communication and social mobilisation strategies have been deployed to 
encourage immunisation uptake in SSA with various degrees of success. However, these 
efforts are mostly focused around supplemental immunisation campaigns and under-
prioritised in resource allocation in routine immunisation budgets. Additionally, impact 
evaluation research of the different strategies on vaccination uptake is inadequate, 
with minimal literature coming particularly from the Central African region.
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Recommendations
1. Funders and managers of immunisation programmes should aim to maintain a balance 
between investment in the essential components of an immunisation system (resources 
that enable programme readiness) and work force capacity to design and execute 
implementation strategies. This includes deployment and recurrent training of HCW 
to fully comprehend vaccines and their effects, the immunisation support practices 
and policies, and the community needs and desires. This will empower them to tailor 
appropriate communication and social mobilisation strategies to address knowledge 
deficiencies and inaccuracies among caregivers and community leaders.
2. Researchers in SSA should address evidence gaps in the areas of impact evaluations 
of the various communication and social mobilisation techniques employed to address 
knowledge deficiencies and inaccuracies regarding immunisation. This will provide the 
evidence base needed by policy and decision-makers to select the most appropriate 
options for the various settings in the region. Special consideration should be made in 
Central African countries where evidence gaps are pervasive.
Trust – relationships and allegiances
Conclusions
1. Trust in the overall healthcare system directly impacts on the trust in the immunisation 
programme in SSA. The conduct of HCW during health seeking visits and community’s 
perceptions of political and socio-economic climates affect individual and community 
group trust relationships respectively with the healthcare system.
2. Socio-cultural ties and influences, including culture and religion, play a significant role in 
decisions regarding uptake of vaccinations and are primary causes of hesitancy in SSA.
3. While some measures of success have been demonstrated in the application of various 
trust building strategies — including training of HCW, use of community change agents, 
building alliances and partnerships in a contextualised approach, and establishment 
of National Immunisation Technical Advisory Groups — there is a consistent lack of a 
systematic evaluation of the impact of these approaches on the uptake of immunisation 
in SSA.
Recommendations
1. Political and socio-economic leaders should be cognisant in their actions of the sensitivity 
of the immunisation programme to overall confidence in the healthcare system. Actions 
that engender trust and confidence in the healthcare systems should be promoted.
2. Researchers should conduct longitudinal studies evaluating the impact of different trust 
building interventions on the uptake of immunisation in SSA over time, using defined and 
uniform indicators in order to ease comparability. These would then benefit decision 
makers to guide policy creation based on sound scientific evidence.
Convenience – access and reliability
Conclusions
1. Physical barriers that create longer travel times from communities to health facilities make 
it inconvenient for communities to access immunisation services and for health workers 
to deliver immunisation services to underserved communities. Socio-economic barriers, 
including heavy workloads and inflexible working environments (particularly for blue 
collar workers) and lack of family support, make it difficult for caregivers to take time off 
to access immunisation services. Considering that a majority of workers in SSA are blue 
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collar and considering the large populations of displaced persons with no family support, 
there exists a significant challenge to immunisation service provision in the region.
2. Poor service delivery on the part of HCW as poor customer services, long waiting times 
and inconsistent availability of immunisation services deter immunisation service uptake. 
Underlying this poor service delivery are systemic challenges such as heavy healthcare 
workloads due to low health-worker to population ratios, lack of motivation, poor 
remunerations and resulting high staff turn-over, and limitations within the immunisation 
supply chain.
3. Strategies deployed aimed at bringing immunisation services closer to communities 
through establishment of more community-based immunisation posts, conducting 
outreaches, task shifting, and use of community-based HCW, have shown anecdotal 
improvements in immunisation coverage.  
4. Interventions aimed at improving vaccine security, including re-designs in the immuni-
sation supply chains, use of controlled temperature chains, local manufacturing, and 
pooled financing and procurement mechanisms, though fairly recent, have been shown 
to have positive impacts on immunisation coverage based on early implementation 
stage assessments. However, a lack of comprehensive information on the part of 
the manufacturing industry has been identified as a challenge to the sustained 
implementation and scalability of these interventions.  
Recommendations
1. District level leadership should own and support the implementation of the WHO/UNICEF 
designed Reaching Every District/Reaching Every Child (RED/REC) strategy to reach 
every child with immunisation services implemented at the sub-national level through 
lobbying for sufficient fund allocation, progress monitoring, and supporting community 
engagement.
2. National level immunisation sector leadership should ensure that HCW at service delivery 
points are sufficient (based on task requirements and populations served) and well-
motivated. Innovations such as task shifting should be encouraged and supported 
at district levels through regular training, supervision, and, where feasible, monetary 
compensation. Additionally, they should prioritise immunisation supply chain (iSC) 
management through capacity building of iSC experts and their involvement in top 
management decision making.
3. Regional level leadership, including WHO AFRO and African Union, should encourage 
national leaders to commit to the long-term vision of local vaccine manufacturing as 
a means to ensure sustainable vaccine supply for the region by putting in place the 
foundational structures necessary, including building local expertise, incentives for 
private sector investment, strengthening in-house research and development, and 
requisite infrastructure developments.
4. Immunisation development partners and Civil Society Organisations should incentivise 
and lobby for greater transparency from industry partners in order to support iSC 
innovations such as controlled temperature chains, and alternative energy sources.
5. Researchers should further study and evaluate impacts of innovations aimed at securing 
vaccine supply such as pooled procurement and longer-term implementation of 
immunisation supply chain re-designs on vaccination coverage.
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Political ownership - financing, community ownership and an enabling 
environment
Conclusions
1. The immunisation programme in SSA is still largely dependent on external funding for its 
operations, putting the programme in a risky and unsustainable position. While there has 
been an overall positive trend in national governments’ commitments to taking greater 
ownership of immunisation financing, translating this into practice has not been uniformly 
realised. Of particular concern is financing for newly introduced vaccines that have 
been observed as the biggest cost driver for incremental immunisation financing needs 
in the region.
2. Civil Society Organisations (CSOs) are key interlocutors in facilitating ownership at the 
national level by holding governments accountable to their mandates, and at the 
community level by fostering participatory inclusion and accountability of sub-national 
governments and the populace.
3. SSA has been historically vulnerable to disruptive environmental forces such as political 
and civil unrest, natural disasters, and disease outbreaks resulting in armed conflicts, mass 
population movements, flooding, droughts, famines, and humanitarian emergencies. 
These negative environmental events are disruptive to the region’s fragile health systems 
and especially to the highly sensitive immunisation programme, putting the region at a 
risk of vaccine-preventable disease outbreaks and loss of immunisation gains already 
made.
Recommendations
1. National governments, being held accountable by regional bodies and national 
institutions such as the African Union and National Parliaments, should act upon financing 
commitments made in the Addis Declaration on Immunisation (ADI) to gradually and 
impactfully increase their budgetary allocations to immunisation and provide the 
requisite oversight to the transparent and equitable use of funds provided. 
2. National and sub-national immunisation programme managers, with the support of 
CSOs, should provide the enabling financing advocacy and decision support frameworks 
required by decision-makers. They can do this by developing and making available clear 
and timely planning, budgeting, and accounting documents; making use of standard 
tools such as country multi-year plans that outline the country’s contextual priorities; as 
well as demonstrating value for money invested in the immunisation program. 
3. National political leaders should be cognisant of the inevitable intertwining of political 
and health security agendas and should thus ensure peaceful and secure communities 
through application of democratic principles of governance and equitable share of 
national resources. This will minimise incidents of conflict, which have significant negative 
impacts on the immunisation programme. In cases of humanitarian emergencies, lessons 
learned from the region to ensure continued vaccination of children should be applied.
4. The Africa Centres for Disease Control and Prevention should provide evidence-based 
technical tools and measures that can be adapted to ensure that the contextual 
dynamics in individual African countries are taken into account in all disease pandemic 
mitigation responses in order to minimise adverse effects on healthcare programmes 
including immunisation.
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Overarching conclusions and recommendations
SSA is predominated by countries categorised as low-income, a rapidly growing population 
with low levels of education, a significant burden of displaced persons, and a weak 
healthcare system. Still, some recognisable progress has been made thanks to the concerted 
efforts of immunisation stakeholders ranging from technical staff at all levels of government, 
researchers, CSOs, and development partners. 
Based on the region’s demographic challenges, it comes as no surprise that the root causes 
of low coverage and under-immunisation are summarised under deficiencies in knowledge, 
shortage of trust, and difficulties in accessing reliable immunisation services. The identified 
strategies to address these challenges (including increasing access to accurate information, 
building trust, and removing barriers to accessing reliable immunisation services) centre 
around national political commitment and ownership of the immunisation programme. 
Whilst the study identified some significant shortages in empirical research evidence, 
particularly in the area of effectiveness of strategies deployed to respond to identified root 
causes for low coverage and under-immunisation in SSA, the lack of such evidence should 
not be used as a defence for inaction. Where contextualised anecdotal evidence exists, 
this should continue to inform decision makers as researchers conduct more systematic 
studies that will inform scaling initiatives. 
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REPORT OUTLINE
This report is divided into four sections:
1. The introduction gives a snapshot of sub-Saharan Africa, describes the rationale of the 
study, provides the Statement of Task, and outlines the different methodologies and 
processes used in the study. 
2. The background describes the immunisation landscape in sub-Saharan Africa, with a 
specific focus on overall coverage using diphtheria-tetanus-pertussis third dose as a 
proxy indicator for coverage in the first year of life, second dose of measles-containing 
vaccine for coverage in the second year of life, and coverage of newly introduced 
vaccines using rotavirus vaccine as a proxy. 
3. The root causes of low vaccination coverage and under-immunisation in sub-Saharan 
Africa outlines evidence of underlying causes of low vaccination coverage and under-
immunisation in sub-Saharan Africa categorised under four sub-themes: i) knowledge, 
ii) trust, iii) convenience, and iv) political ownership. Evidence of interventions that have 
been implemented and/or proposed in published literature to address the identified root 
causes are also highlighted. All the evidence reviewed led to summary conclusions and 
recommendations of the consensus study. 
4. The last section highlights overarching key conclusions and recommendations. 
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1. CONCISE  
DESCRIPTION ON 
 THE STUDY
Based on the high levels of vaccine preventable diseases (VPDs) in children in SSA, the 
purpose of this consensus study is to: 
1. Identify the contextual underlying causes of persistent low vaccination coverage and 
under-immunisation of children under two years of age in countries within SSA using 
the expertise that exists within the SSA academies of science as well as other relevant 
stakeholders.  
2. Provide evidence-based recommendations to national and international stakeholders 
taking into consideration both financial and non-financial factors to address the 
challenges for the improvement of the overall vaccination strategies in SSA. 
For the purposes of this consensus study, three key indicators were used to assess the extent 
of immunisation practices in SSA countries. The three indicators were: 
1. Diphtheria-tetanus-pertussis third dose (DTP3) coverage as a WHO/UNICEF indicator for 
equity of vaccination coverage.
2. Measles-containing vaccine second dose (MCV2) coverage as an indicator for 
vaccination coverage in the second year of life.
3. Rotavirus	vaccine	final	dose	coverage as a marker of newly introduced vaccines.
1.1 Study objectives 
In order to understand the root causes of low vaccination coverage and under-immunisation 
of children in SSA, ASSAf and UNAS convened a committee of experts. The eleven-member 
committee of trans-disciplinary experts was drawn from SSA countries (Annex 1). 
The study brief to the committee was to:
a) Use published literature and other relevant data sources to assess the trends over the 
last ten years regarding vaccination coverage in SSA.
b) Analyse and comment on the drivers for change in countries that were formerly poor 
performers who managed to register improvements in vaccination coverage over 
the years.
c) Document the gaps and bottlenecks to immunisation in persistently poorly performing 
countries and to identify the root causes of low vaccination coverage and under-
immunisation in those countries.
d) Use an evidence-based approach to provide recommendations for overcoming 
the root causes of low vaccination coverage and under-immunisation in SSA, with 
emphasis on priority actions to be undertaken to inform stakeholders with an interest 
in overcoming these barriers.
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1.2 Study methodology
The study proposal (approved by councils of both academies) outlined a combination of 
methodologies aimed at ensuring that study objectives produced responses that: (i) are 
evidence-based, (ii) include local experiences and relevance (with examples of innovation), 
and (iii) make contextualised and implementable recommendations. 
The detailed study methodologies included:
1. Closed committee meetings involving deliberations on the study objectives (Statement 
of Task), review of evidence, multi-disciplinary debates, and development of evidence-
informed conclusions and recommendations that address the study objectives.   
2. Thematic regional workshops that were open to the public (detailed agendas in Annexes 
2 and 3).
3. The involvement of an expert researcher writer who was tasked with spearheading the 
research and compiling the report as per guidance by the committee.
Table 1 lists the key methodologies and activities that were undertaken to address the 
study objectives between June 2018 and March 2020. The report is based on these diverse 
methodologies.
Table	1:		Key	study	methodologies	and	activities	undertaken,	June	2018	to	March	2020
Activities Location and duration Purpose
Closed committee 
meetings
1. Held in Johannesburg, 
South Africa on 31 July to 1 
August 2018
2. Held in Kampala, Uganda 
on 1 March 2019
3. Held in Johannesburg, 
South Africa on 18 to 19 
November 2019
Deliberations on all aspects of 
the study including:
• Review of study objectives; 
stakeholder views and 
inputs, the evidence; 






1. Held in Johannesburg, 
South Africa on 30 to  
31 July 2018 (Annex 2)
2. Held in Kampala, Uganda 
on 27 to 28 February 2019 
(Annex 3)
• Mainly as information 
gathering processes 
towards the study.
• Presentation and sharing 
of evidence on different 
aspects of the study.
Research and review 
of published and grey 
literature
Done collectively, individually, remotely - including through 
electronic platforms such as teleconferencing - and physically 
between June 2018 up to March 2020. All aimed towards 
addressing the objectives of the study. 
Consultations with 
experts outside of the 
committee
Done between June 2018 and March 2020 for the purpose 
of ensuring the report adequately addressed the study 
objectives. 
Systematic reviews
Root causes of low vaccination coverage and under-
immunisation in SSA
Interventions to address the root causes of low vaccination 
coverage and under-immunisation in SSA
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1.3 Study design 
The mixed methods study design used in this study was largely informed by the Consensus 
Development Panel (CDP) model that brings together experts to produce multi-disciplinary 
responses to a specific statement of task. Its advantages include an inter-disciplinary 
composition, accessibility, evidence-based nature and ownership by experts  (Waggoner, 
Carline, & Dunning, 2016). 
The CDP model ensures that the language of the study remains easily understandable to a 
lay audience, and that a broad range of perspectives is included. Furthermore, the model 
encourages more evidence-based opinions through its reliance on published literature as 
the grounds for dialogue (Waggoner, Carline, & Dunning, 2016). The drawbacks associated 
with the CDP model include vocal member domination and the “bandwagon effect”, 
which were mitigated through several face-to-face meetings, and an extensive period of 
remote contribution where committee members were individually encouraged to review 
the documents and provide direct online feedback to the secretariat. 
The completed draft consensus study report was distributed for peer-review to experts (both 
from within and outside sub-Saharan Africa) approved by councils of both academies. 
Peer-reviewers responded to six questions: i) does the report respond sufficiently to the study 
objectives? ii) does the report remain within the scope of the study objectives? iii) are there 
any crucial areas of evidence missing in the report? iv) does the report appear balanced 
and apolitical? v) do the conclusions follow logically from the evidence presented? and, vi) 
do the recommendations follow logically from the conclusions?  
Peer-reviewers’ comments were addressed, and consensus was obtained from the 
committee before final sign off/approval from councils of both academies. 
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2. SUB-SAHARAN 
AFRICA IN  
PERSPECTIVE
2.1 Socio-demographic context
Africa consists of 54 countries with 48 geographically situated within SSA as shown in Figure 
1. All SSA countries, except Sudan and Somalia, fall under the World Health Organisation 
(WHO) Africa Region (AFR) (WHO Africa Region, 2020) (World Bank, 2019a)3.
Figure 1: Map of Africa highlighting countries in SSA and WHO African Region
Source: Author derived using WHO 2018 and World Bank 2018 Literature 
SSA is home to over one billion people, and the population is estimated to grow to over 
two billion people by 2050 (World Population Prospects, 2017) with Nigeria, Ethiopia and 
the Democratic Republic of the Congo being the top three most populous countries. SSA is 
predicted to account for 38% of all births globally by 2025, and is currently the region with 
the highest number of births, with the trend predicted to persist for the rest of the century 




SSA Countries outside WHO Africa
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(UNICEF, 2019). Nine of the ten countries globally with the highest fertility rates are from SSA. 
On average, women in these high fertility SSA countries have five or more children over 
their lifetime (United Nations, 2015a&C) The World Bank statistics show that the overall life 
expectancy at birth in SSA is 60.88 years (World Bank, 2019b) 
SSA has the highest rate of early childbearing (above 178 births per 1,000 girls aged 15 - 
19), with the Central African Republic, Niger, Chad, Angola and Mali having the highest 
adolescent birth rates. For the 2010 – 2015 period, over 45% of women aged 20 – 24 were 
reported to have given birth for the first time by age 18 (UNICEF, 2019).
SSA is the region with the highest global death rate for children under the age of five, where 
child mortality is projected to reach 56.6 deaths per 1,000 live births by 2030. By the end of 
the century the under-five mortality rate is expected to be about five times higher than the 
lowest regional level observed at present (United Nations, 2019). 
Figure	2:	Number	of	births,	by	UNICEF	region,	1950		-2050
Source: UNICEF 2015: Children in Africa, Key statistics on child survival, protection and development.  
(UNICEF, 2015) 
Poverty is prevalent across SSA with 22 of the 48 countries classified as low-income countries 
(LICs) with a gross national income (GNI) per capita of US$1.025 or less, while 17 are lower-
middle income countries (LMICs) with a GNI per capita of US$1.026 to $3.995 thousand, and 
only nine are classified as upper-middle income countries with a GNI per capita of US$3.996 
to $12.375 thousand  (World Bank, 2019a). 
While approximately 60% of the SSA population lives in rural areas, urbanisation is evolving 
rapidly and it is estimated that the urban population will be three times larger by 2050 (Simkins, 
2019). Much of this urbanisation is unplanned and poorly managed (African Union, 2018). 
About 70% of workers in SSA are in vulnerable employment against the global average of 
46.3%  (International Labour Organization, 2018).
Eight of the ten countries globally with the lowest pre-primary net enrolment rates are in SSA, 
with only 6% of young people in the region in 2015 enrolled at higher education institutions 
compared to the global average of 26% (UNESCO Institute for Statistics 2019). Across SSA, 
nine million girls aged six to eleven years will never go to school compared to 6 million boys 
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On the global scale, SSA is host to the largest number of persons of concern to the United 
Nations High Commission for Refugees (UNHCR). By the end of 2017, there were an estimated 
24.2 million people of concern in the region, an increase of 4.6 million since 2016. This includes 
6.3 million refugees and 14.5 million internally displaced persons (IDPs). In the first half of 
2018, the numbers increased, with some 170,000 new refugees and over two million new 
IDPs - mainly from the Central African Republic, the Democratic Republic of the Congo, 
Nigeria, Somalia and South Sudan  (United Nations High Commissioner for Refugees, 2018).
2.2 Immunisation policy context and outlook
Two scenarios make the timing of this study pertinent: a) the nexus of evaluation timings of 
global and regional development agenda cycles, and b) the projected future of vaccines 
and population dynamics in the region.
2.2.1  Immunisation development agenda and timing of cycles
On the global stage, the mid-interval point of the Sustainable Development Goals (SDGs) 
is approaching (2015 - 2030), which emphasises equity under the “leave no one behind” 
mandate. SDG 3 is of relevance as it seeks to “ensure healthy lives and promote the 
wellbeing for all at all ages” and the specific target SDG 3.2 aims to “end preventable 
deaths of new-borns and children under 5 years of age, with all countries aiming to reduce 
neonatal mortality to at least as low as 12 per 1,000 live births and under-5 mortality to at 
least as low as 25 per 1,000 live births by 2030”  (United Nations, 2015b) 
A new global immunisation agenda for the next decade, Immunisation Agenda 2030, 
which aims to ensure that everyone everywhere has access to immunisation, has just been 
launched. This follows the end of the antecedent Global Vaccine Action Plan (GVAP) 2014 
- 2020 and the regional version, the WHO African Regional Strategic Plan for Immunisation 
(RSPI) (2014 - 2020), whose goal was achieving universal immunisation coverage and 
reducing mortality and morbidity from VPD within the WHO Africa Region by the end of 
2020. Its first strategic objective was “to improve immunisation coverage beyond the current 
levels with specific targets including DTP vaccine coverage to reach 90% region-wide by 
the end of 2020 and at least 37 countries to introduce the rotavirus vaccine by 2020” (WHO, 
2013b)
Also starting up is a new immunisation funding strategy dubbed “The Gavi 5.0 (2021 - 2025) 
strategy” which will operate on a principle of giving missed communities first priority, focussing 
on children missing out on vaccination, including among migrants, displaced persons and 
other vulnerable populations. In addition, Gavi’s new vaccine investment strategy plans 
to assist countries with prioritising and financing new vaccines in order to reduce their VPD 
burden  (Gavi, 2019).
Regionally, the 10-year interval point for the African Union Agenda 2013 - 2063 is fast 
approaching, which has a vision of “an integrated, prosperous and peaceful Africa, driven 
by its own citizens, representing a dynamic force in the international arena” and whose 
top mandate point is “a   prosperous Africa based on inclusive growth and sustainable 
development, healthy and well-nourished citizens” (Commission, A.U, 2015). The target is 
that “malnutrition, maternal, child and neonatal deaths as at 2013 would be reduced by 
half by 2023 (Commission, A.U, 2015).
Other policy frameworks of interest to the study are summarised in Table 2.
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2.2.2  Outlook for immunisation in Africa
Progress in new vaccine development indicates that there may be more vaccines 
forthcoming for possible introduction in SSA, in addition to those already planned for 
introduction. These include vaccines against Group B Streptococcus, HIV, Ebola, malaria, 
dengue, tuberculosis, RSV, E.coli and shigella (WHO, 2019). The vaccine against COVID-19 
is also at hand. With the rapidly growing population, the majority of countries in SSA are 
in a situation where immunisation programmes must be scaled up, not only to make up 
for current shortfalls in coverage, but also to prepare for the increasing demand and 
introduction of new vaccines. The WHO African Regional Immunisation Technical Advisory 
Group has highlighted a need for the region’s stakeholders to develop new innovative 
immunisation strategies in line with its changing demographics  (WHO, 2017).
Table 2: Global and regional immunisation agendas and plans
Plan/Strategy/ 





Keep universal access to immunisation at the forefront of efforts to 
reduce child mortality.
Increase and sustain domestic investments and funding allocations for 
immunisation.
Address the persistent barriers in vaccine and healthcare delivery 
systems, especially in the poorest, vulnerable and most marginalised 
communities.
Develop a capacitated African research sector to enhance 
immunisation implementation and uptake.
Build broad political will for universal access to life-saving vaccines.
Promote and invest in regional capacity for the development and 
production of vaccines.
Business 




continent 2018 - 
2030
Adopt a comprehensive approach of immunisation over the life-
course and consider its broader impact on health care.
Focus its efforts in supporting countries to build stronger immunisation 
systems.
Adopt a tailored approach to countries, dependent on the maturity 
of their immunisation system.
Reinforce coordination and communication with immunisation 
stakeholders.
Strengthen its accountability framework to better achieve efficiency 
and transparency.
Progressively phase out its technical support to countries as they gain 
maturity.
2.3 Unvaccinated and under-vaccinated children in SSA
An analysis of global trends for unvaccinated and under-vaccinated infants in terms of 
absolute numbers has shown a downward trend over the past decade, as the global 
immunisation coverage increased over time (WHO, 2020) (VanderEnde, 2018). However, 
there has been overall stagnation for the African Region (Figure 3) which takes the biggest 
share at nearly 50% of all unimmunised and under-immunised infants for the decade 
2010 - 2019. Vaccination uptake and utilisation in SSA faces several challenges, including 
missed opportunities that warrant special focus (Madhi & Rees, 2018). Closer analysis of 
the vaccination status of children in SSA shows that while there are overall positive trends 
in the number of immunised children, there is indeed stagnation in the number of both 
unimmunised and under-immunised infants over the last decade (Figure 4).
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Figure 3: Global trends on DTP3 coverage and number of unvaccinated or under-vaccinated 
infants by WHO region 2010-2019
Source: WUENIC Analytics 2020 (WHO 2020)
 
Figure	4:	Vaccination	status	(fully	vaccinated,	incompletely	vaccinated,	and	unvaccinated)	
of children in SSA 1990-2019
Source: Global Burden of Disease, Injuries, and Risk Factors Study 2019  (GBD, 2019)
AFR 9.4 SEAR, 3.0  , 3.1 AMR 2,3 WPR1.4
EUR
0.5
















































































































IncompletelyVaccinated (DTP1 or DTP2)
UnVaccinated (DTP0)
28 Root Causes of Low Vaccination Coverage and Under-Immunisation in Sub-Saharan Africa
Consensus Study Report
DTP3 coverage at regional, national and sub-national levels
The percentage of children receiving DTP3 is routinely used as an indicator for overall 
vaccination coverage for children in their first year of life (Burton et al. 2009). The target of 
the Global Vaccine Action Plan (GVAP) was DTP3 coverage of at least 90% at national level 
and at least 80% coverage in every district by 2020  (World Health Organization, 2013). The 
WHO African Region registered a slight increase of DTP3 coverage from 71% in 2015 to 74% 
in 2019 (WHO, 2020). However, as  (Ridpath, et al., 2017) (Metcalf, et al., 2015) point out, 
the regional coverage score does not give a true picture of the performance of individual 
countries in SSA, which is highly varied over time (Figure 5). 
More detailed studies also highlight the true vaccination coverage disparities that exist 
even within countries  (Ikilezi, et al., 2020),  (Utazi, et al., 2019),  (Mosser, et al., 2019) and 
also observed that countries with the largest sub-national relative inequalities in coverage 
were also among those with the lowest national level coverage, including Nigeria (where 
2016 DTP3 coverage for the district level ranged from 7% to 203% of the national average), 
Chad (20% to 213%), Ethiopia (18% to 172%), and Angola (26% to 160%). However, large 
relative inequalities at the district level were also noted in some higher-coverage countries, 
including Kenya (44% to 114% of the national average) and Tanzania (50% to 107%).
In assessing the drivers for change in DTP3 coverage, (Restrepo-Mendez, et al., 2016) found 
that countries where the national vaccination coverage levels progressively improved over 
the period 1990 - 2010 (for example in Mozambique and Madagascar), class-based inequality 
favouring vaccination access for the wealthy decreased over time. For Mozambique in 
particular, much of the increase seen in the national DTP3 vaccination coverage was linked 
to increasing coverage in the poorest quintile of the population. (Restrepo-Mendez, et al., 
2016), (Bao, et al., 2018) found that the drivers for Rwanda’s successful DTP3 vaccination 
coverage over time were strong, high-level political will; multi-level accountability; effective 
use of funding; initiatives with development partners; integrated health information; and 
community-level data collection. 
These drivers are replicable in other SSA countries. In terms of the impact of urbanisation, 
(Restrepo-Mendez, et al., 2016) found that in the 36 SSA countries studied, only seven had 
mean vaccination coverage rates higher in rural versus urban areas, with this difference 
being statistically significant only in eSwatini. In Ethiopia, which showed the greatest absolute 
pro-urban inequality, the mean level of full vaccination coverage in urban areas was 28 
percentage points higher than that in rural areas. Côte d’Ivoire, Madagascar, and Nigeria 
also showed pro-urban differences of at least 20 percentage points. Also, although most 
countries showed higher levels of full vaccination coverage among boys than girls, such 
gender-related differences were less than three percentage points in each of the countries 
and only achieved statistical significance in Mali and Somalia. The Global Polio Eradication 
Initiative (GPEI) with its substantial partner funding, has also been documented to have had 
a positive effect on routine vaccination coverage (Van den Ent, et al., 2017) 







































































































































































































































































































































30 Root Causes of Low Vaccination Coverage and Under-Immunisation in Sub-Saharan Africa
Consensus Study Report
2.4 Second dose of measles containing vaccine (MCV2) coverage
While the WHO issued a recommendation in 2009 for introducing MCV2 in the second year 
of life, adoption of this recommendation in SSA countries has been limited by the prerequisite 
of achieving over 80% MCV first dose (MCV1) coverage for three consecutive years (WHO, 
2019). In 2016, this pre-condition was lifted following a performance assessment by the WHO 
Strategic Advisory Group of Experts on Immunisation. Of the 23 countries globally that had 
not introduced MCV2 and which did not meet the pre-2016 introduction criteria,19 were in 
SSA (Beillik & Davis, 2017). Of the 29 SSA countries that had introduced MCV2 by 2019, only 
three countries (Rwanda, Eritrea and Cape Verde) had achieved 90% coverage while the 
rest had achieved between 50% and 79% coverage  (GBD, 2019). Figure 6 shows the 29 SSA 
countries that had introduced MCV2 by 2019 (Chirwa, Wilkins, & Mercer, 2020).
Gavi’s vaccine introduction grant has been a key driver for the introduction of MCV2 in 
Africa. Of the 26 countries that introduced MCV2 in 2017 in Africa, 18 were Gavi-eligible 
countries while 8 were self-financing countries (Sambala, Wiyeh, Ngcobo, Machingaidze, 
& Wiysonge, 2019),. Most SSA countries provide MCV2 between 15 and 18 months of age, 
however, Mauritius and Seychelles provide MCV2 at school entry and South Africa provides 
it at 12 months of age (Masresha B. G., et al., 2018).
As with other vaccines, coverage for MCV2 varies widely across SSA countries. MCV2 
coverage was a mere 18% in 2015 in the region, growing slightly to 26% in 2018  (WHO, 
2019). Country-level analyses showed problems with data recording, possibly resulting 
in inaccurate reporting from the subnational levels (Masresha B. G., et al., 2018), hence 
nationally reported figures may be different from actual coverage  (Chirwa, Wilkins, & 
Mercer, 2020).
 
Figure 6: MCV2 coverage in SSA countries by nationally recommended age 2010 - 2019
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2.5 Rotavirus vaccination coverage
The highest rates of rotavirus-associated mortality in children younger than five years are 
in SSA  (Tate, Burton, Boschi-Pinto, & Paladin, 2016). Of the five countries that account for 
more than 50% of all rotavirus deaths globally, three (Nigeria, DRC, and Angola) are in SSA 
(Steel, et al., 2019). The WHO recommended global introduction of rotavirus vaccination 
in 2009 (using either Rotarix® or RotaTeq® vaccines), with the first dose to be administered 
at six weeks of age, along with DTP vaccination for protection prior to natural rotavirus 
infection (WHO, 2013b). Rotarix® is administered orally in a 2-dose schedule at the time of 
DTP dose 1 (DTP1) and DTP dose 2 (DTP2) with an interval of at least four weeks between 
doses. RotaTeq® is administered orally in a 3-dose schedule at the same time as DTP1, DTP2 
and DTP3, with an interval of at least four weeks between doses  (WHO, 2013b).  The only 
SSA country to introduce the rotavirus vaccine in 2009 was South Africa, a self-financing 
country. By 2017, 34 countries (28 Gavi-eligible; 6 self-financing) had introduced the vaccine 
(Sambala, Wiyeh, Ngcobo, Machingaidze, & Wiysonge, 2019), (Platts-Mills & Steele, 2018). 
Unlike most new vaccine introductions in the past 20 years, the global leaders in introducing 
rotavirus vaccination have been LICs and LMICs in Africa, with 77% (37 of 48 SSA countries) 
having introduced or been approved to introduce the vaccine by 2019  (GBD, 2019). In 
addition, 44% of SSA children live in countries that were approved to introduce the vaccine 
only in 2019, including Nigeria and the DRC  (Abou-Nader, et al., 2018). The need to expand 
cold chain capacity to accommodate rotavirus vaccines delayed its introduction in 
some countries, for example Malawi’s existing cold chain capacity was only 50% of what 
was needed for rotavirus vaccine introduction  (Madsen, et al., 2014). In response to this 
challenge, Gavi-eligible countries received support to expand their cold chain capacity. In 
addition, newer rotavirus vaccines are available in multi-dose vials, reducing their impact 
on storage capacity  (Rota Council, 2019).
In most SSA countries, coverage with the last dose of rotavirus vaccine is comparable to 
DTP3 coverage (Figure 7) (Rota Council, 2019)
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Figure 7: Comparison of DTP3 and rotavirus vaccine series completion for countries that 
have introduced the rotavirus vaccine in SSA
Source: Global Burden of Disease, Injuries, and Risk Factors Study (GBD 2019)
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SSA in Perspective: Section Summary 
Compared to other world regions, sub-Saharan Africa (SSA) is home to the highest 
number of unimmunised and under-immunised infants, has the greatest share of the 
burden of vaccine-preventable diseases and, consequently, the largest portion of the 
millions of under-five deaths annually. These statistics are gravely concerning, especially 
because SSA has the fastest population growth in the world.
Unfortunately, despite the global availability of efficacious and cost-effective vaccines, 
immunisation coverage in sub-Saharan Africa is sub-optimal, as shown by the DTP3 
regional coverage that has plateaued at around 75% for the last five years. Vaccine 
introduction grants from Gavi, the Vaccine Alliance, have been pivotal in spurring 
introduction of new vaccines across the region; including the introduction of the rotavirus 
vaccine, pneumococcal conjugate vaccine, and measles second dose. However, 
uptake for vaccines administered in the second year of life is particularly dismal.
These observations of under-performance are not uniform across countries in the region, 
or across time. Some countries have stood out as having high immunisation coverage 
and some previously poor-performing countries have made significant improvements in 
the last ten years. This provides a point for peer examination and learning.
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3.1 Introduction
3.1.1 Root cause analysis
Generally, root causes are those factors and issues underlying a problem that might not 
be obvious but can be identified as the cause of a problem, usually through inferential 
statistical analysis. 
Figure 8: Root causes analysis tree illustration.
Source: Adapted from (Operational Excellence Consulting, 2014))
Figure 8 provides a diagrammatic illustration. In the context of this study the problem is low 
vaccination coverage and under-immunisation in SSA. The problem, when not addressed, 
leads to symptoms or undesirable health outcomes. In this context, VPDs in children are the 
outcomes. 
3.1.2 Theory of change
One way to address complex societal problems is to use a theory of change (ToC). ToC 
models use backwards mapping to “begin with the end in mind” and are useful because 
they force the evaluator to start from large-scale goals and work backwards to interventions 
that will achieve the goals (Anderson 2004). ToC allows for multiple causal pathways, 
levels of interventions and feedback loops which better reflect the reality of how complex 
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interventions achieve their impact. Secondly, the articulation of the evidence base as the 
rationale for each link (pre-condition) in the causal pathway ensures that each step along 
the causal pathway is evidence based (De Silva, et al., 2014). This study looks at the root 
causes of low immunisation coverage and under-immunisation in SSA, studying demand-
side and supply-side root causes as well as cross-cutting issues between them. Having 
reviewed the evidence on interventions to address these root causes, this study came up 
with a ToC with four overlapping topical sub-themes: Knowledge, Trust, Convenience, and 
Political Ownership. 
Figure 9: Theory of Change for low coverage 
and under-immunisation in SSA
3.2	 Knowledge	-	deficiencies	and	inaccuracies
Knowledge deficiencies and inaccuracies among various stakeholders are one of the 
underlying root causes for low coverage and under-immunisation in SSA.
3.2.1 Demand-side knowledge deficiencies and inaccuracies
On the demand side, a systematic review of the barriers to childhood immunisation in SSA 
found that parents not being knowledgeable of immunisation was the most frequently and 
consistently reported barrier to childhood immunisation (Bangura, et al., 2020), (Wiysonge, 
Uthman, Ndumbe, & Hussey, 2012). (Tefera, Wagner, Mekonen, Carlson, & Boulton, 2018) 
found that mothers in Ethiopia indicated a variety of reasons for not completing the 
recommended vaccination schedule for their children, which included attitudes about 
vaccines or misperceptions about vaccinations, such as fear of side reactions, hearing 
rumours, or being unaware of the need for vaccination or the need to return to the vaccine 
clinic to complete the vaccine series.  (Braka, et al., 2012) through focus group discussions in 
Uganda also found that a general lack of information among caretakers about immunisation 
benefits, immunisation safety concerns, and misconceptions were to blame for not taking 
children for immunisation. Some community members were reported to refuse immunisation 
services due to the belief that vaccines were not safe for their children. The knowledge of 
fathers’ also plays a role as overall family decision-makers and in situations where fathers did 
not understand immunisation, they refused to allow their children to get vaccinated  (Ebot, 
2014) or refused to facilitate mothers’ to access immunisation services for their children 
(Babirye, et al., 2012).
Some demographic correlates for knowledge deficiencies have been pointed out as 
predisposing factors to un- and under-immunisation such as poverty, living in certain 
disadvantaged regions within a country, previous contact with health facility through 
antenatal care or delivery, refugee status, and mother’s education level  (Wairiri, et al., 
2019),  (WHO, 2016). In Togo, children under the care of illiterate mothers were 1.7 times 
more likely to be poorly vaccinated compared to those with secondary education level 
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and above while in Nigeria mothers with no education were 31% less likely to have fully 
vaccinated their children than mothers with secondary or higher education and rural-urban 
migrants were less likely to be fully immunised compared to the general population (Landoh, 
et al., 2016),  (Antai, 2011), (Awoh & Plugge, 2016). 
However, a deeper analysis study in Ethiopia found that the mother’s education level had 
no significant influence on immunisation outcomes, but rather affected health education 
on the importance of immunisation (Lakew, Bekele, & Biadgilign, 2015), (Atkinson & Cheyne, 
1994) also noted that in areas where immunisation is generally accepted, lack of specific 
knowledge on timing for immunisation may not necessarily affect coverage if health workers 
provide regular motivation and screening of children brought to health facilities for curative 
care. For instance, in Zambia only 57% of mothers knew that the poliomyelitis immunisation 
was needed three times, although the coverage was 90%. Less than half of the women 
interviewed knew why tetanus toxoid was given, although the coverage was 68%. Maternal 
age was also found to be a strong predictor of vaccination of a child, with older mothers 
being more likely to have children who were vaccinated compared with mothers who were 
aged less than 20 years (Mutua, Kimani-Murage, & Ettarh, 2011).
Parental knowledge on immunisation was found to be highly influenced by their source of 
information.  (Chidiebere, Uchenna, & Kenechi, 2014) and  (Wiysonge, Uthman, Ndumbe, 
& Hussey, 2012) found that care givers referred to misinformation spread in the media on 
poor efficacy of vaccines and false vaccine attributable side effects as reasons for refusing 
or delaying having their children vaccinated, a phenomenon termed vaccine hesitancy. 
Numerous studies have identified vaccine hesitancy as a growing concern in many SSA 
countries, with quantitative evidence emanating from Ethiopia, DRC, Ghana, Guinea, 
Nigeria, South Africa, and Zimbabwe (Masters, Tefera, Wagner, & Boulton, 2018), (Tefera, 
Wagner, Mekonen, Carlson, & Boulton, 2018), (Larson, et al., 2016),  (Larson, Schulz, Tucker, 
& Smith, 2015), (Kpanake, Sorum, & Mullet, 2018), (Taylor, et al., 2017), (Wong, et al., 2016), 
(Gerede, et al., 2017), (Kriss, et al., 2016), (Pugliese-Garcia, et al., 2018) after their assessment 
of factors influencing vaccine acceptance and hesitancy in three informal settlements in 
Lusaka, Zambia, concluded that parents and caregivers required information on the aims 
of vaccines and their possible adverse effects in order to limit the spread of rumours and 
distrust.
3.2.2 Supply-side knowledge deficiencies and inaccuracies
On the supply side, HCW have been identified as key sources of vaccination information 
for parents and care givers and they play an important role in allaying fears about vaccine 
safety risks  (SAGE, 2014),  (Oku, et al., 2017)). However,  (Bangura, et al., 2020), in their 
systematic review of barriers to immunisation in SSA, found reports where HCWs lacked 
knowledge of vaccine indications and contra-indications and also lacked counselling skills. 
(Braka, et al., 2012) found in Uganda that there was inadequate communication between 
HCWs and caretakers, though health care workers demonstrated knowledge about adverse 
events following immunisation and their management. (Oku, et al., 2017) reported that in 
some health facilities in Nigeria, care givers said that most of the information they received 
from HCWs in clinics focused on other child health strategies (nutrition, childcare, personal 
hygiene) and reported a paucity of information on vaccinations.  (Malande, et al., 2019) 
attributed the lack of health worker knowledge to lack of adequate training. 
Health information systems are recognised as a useful tool in improving data management 
but lack of the required skills to operate these systems and convey data information to 
the target audience has been a major bottleneck among immunisation HCWs in SSA. 
Inaccuracy in data is a major problem observed mainly at the health facility levels and has 
been traced to deficiencies in HCWs’ knowledge and skills in data quality (Nicol, Turawa, 
& Bonsu, 2019). A review of published studies that report on pre- and in-service training 
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with a focus on healthcare providers’ competencies and skills to manage immunisation 
data in LMICs analysed pre-service training in Malawi, Kenya, Ethiopia, Ghana, Lesotho, 
Senegal and Zambia, and in-service training of tutors and lecturers at training institutions 
in Cameroon, Madagascar, Malawi, Mali, Niger, Nigeria, Democratic Republic of Congo, 
Senegal, Tanzania, Uganda, Zambia and Zimbabwe. The findings showed that pre-service 
training does not adequately prepare HCWs, especially clinicians, with the necessary skills 
and competencies to collect, analyse and use data (Nicol, Turawa, & Bonsu, 2019). In-
service training through support supervision was also found to be inadequate.
Other knowledge gaps identified among HCWs that impact on vaccine coverage related 
to immunisation policies and also how to identify vaccine eligible children in order to minimise 
missed opportunities for vaccination (MOV). (Olorunsaiye, Langhamer, Wallace, & Watkins, 
2017) in their review of immunisation facilities in Malawi, Kenya, Tanzania and Senegal, 
reported high MOV prevalence, ranging from 43% to 57%, and documented multiple reasons 
for MOV, including healthcare providers not checking a child’s vaccination eligibility during 
a sick child visit, false contra-indications for vaccination, and hesitancy to open multi-dose 
vaccine vials. A study by (Favin, Steinglass, Fields, Banerjee, & Sawhney, 2012) showed that 
MOV include the refusal to vaccinate due to false contradictions and a mother forgetting 
her child’s vaccination card. Behind this are various fears and misconceptions on the part 
of HCWs and caregivers including that a child should not receive multiple vaccinations 
on the same visit, that a child over 12 months old is too old for the measles vaccination, or 
that underweight children should not be vaccinated (Hanson et al. 2018), (Hanson, Mirza, 
Kumapley, & Nandy, 2018).  (Adamu, Jalo, Habonimana, & Wiysonge, 2020) found that 
children that accompanied a caregiver to a health facility were most often not screened 
for immunisation status by HCWs and presented the largest number of MOV in Northern 
Nigeria.
(Masresha B. G., Luce, Okeibunor, Shibeshi, & Kamadjeu, 2018), when analysing factors for 
MCV2 uptake in the WHO African region, confirmed the pivotal role of HCW in providing 
caregivers with accurate information on immunisation. In São Tomé and Príncipe, 42% of 
caregivers interviewed who knew about the need for MCV2 obtained this information from 
a nurse. However, incidences of insufficient HCW knowledge were cited; for example, in 
Gambia where HCWs were found to be knowledgeable about the justification, policy, and 
technical issues around MCV2 introduction, but some were not able to calculate coverage 
rates, drop-out and wastage rates. In Malawi a majority of HCWs interviewed did not have 
a clear understanding of the policies regarding the vaccination of “sick” children, what to 
do if a child is older than the target age of 15 - 23 months, whether to open a vaccine vial if 
only one child is present, whether to administer missing “infant antigens” to children coming 
for MCV2, or how to document MCV2 in the new registers by age category.  (Wallace, et al., 
2017) had similar findings in Nigeria, where only 55% of HCW interviewed were knowledgeable 
about the multi-dose vial policy for minimising vaccine wastage. Consequently, 30% of 
caregivers indicated that they had been turned away from vaccination at least once and 
the study found that 53% of these children had yet to receive the dose they had missed.
3.2.3 Interventions to address knowledge deficiencies and inaccuracies
Communication interventions are the primary strategy to address knowledge deficiencies 
and inaccuracies regarding immunisation. (Willis et al. 2013) pointed out the various aims 
of immunisation communication, including: inform or educate, remind or recall, teach 
skills, provide support, facilitate decision making, enable communication and enhance 
community ownership.
Oku et al. (2017) asserted that community attitudes are shaped by information and the 
methods used to deliver information to caregivers. (Manakongtreecheep, 2017) reviewed 
seven studies done on SMS vaccine reminders for vaccination (6) and Vitamin A uptake (1) 
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in five SSA countries (Kenya, Nigeria, Zimbabwe, Burkina Faso, and Senegal). Three studies 
considered SMS reminders as the sole intervention and four studies combined SMS reminders 
with an added incentive either together or as a combined intervention, or as another 
monitored intervention in itself, such as cash grants and training opportunities. The findings 
indicated that all studies showed marked improvements in different metrics for vaccination, 
whether an increase in vaccination coverage, decrease in dropout rates, increase in 
completion rate, or decrease in delay for vaccination. This method was also found to be 
more cost-effective when compared to community outreach visits by health workers. The 
shortcomings observed with this avenue were the high level of illiteracy among caregivers, 
language barriers, the lack of access to mobile phones and changes of caregivers’ phone 
numbers. The obstacles could be overcome through suggested innovations like keeping 
messages simple, voice messaging, caregiver tracking (Manakongtreecheep, 2017). A 
review by (Vann, Jacobson, Coyne-Beasley, Asafu-Adjei, & Szilagyi, 2018) assessing the 
effectiveness of various types of patient reminder and recall interventions to improve receipt 
of immunisation, also found that reminder and recall systems were effective for children, 
adolescents, and adults in all types of medical or health settings including private practices, 
academic medical centres, and public health clinics. 
Although internet usage in SSA in comparison to global usage is low, just above 20% and 
above 50% respectively, the trend is steadily increasing in the region (Mahler, Montes, & 
Newhouse, 2019). There is a growing use of mass media as a platform from which people in 
SSA access information, which makes this intervention of possible positive impact (Mahler, 
Montes, & Newhouse, 2019). Mass media refers to communication that is meant to reach 
large audiences or populations. This communication can be written, broadcast or spoken 
and it includes television, radio, advertising, movies, the internet, newspapers, magazines 
and academic publications. Mass media is an important source of information for health 
matters, and, in countries or settings where health systems have been weakened, it might 
be the only source of information (Jung, Lin, & Viswanath, 2015). Depending on how mass 
media is used, it can be effective in a positive or a negative manner and perceptions 
and behaviours about whether to vaccinate can be formed based on mass media 
messaging. (Oubari, Tuttle, Rath, & Bravo, 2015) found that the different forms of mass 
media have different influences in terms of vaccinations, with the visuals and emotional 
messages being viewed as the most effective. One positive example of how social media 
has been harnessed is the 2019 high level decision taken by social media giants Facebook, 
Google, Pinterest, Instagram and Twitter, in which they all agreed to only host science-
based credible information about vaccinations and to remove and block anti-vaccination 
misinformation from their social media platforms (Lancent, 2019). Facebook, which holds 
the largest market share of social media users in Africa, committed to directing its millions 
of users to WHO’s accurate and reliable vaccine information in several languages so as to 
ensure that important health messages reach people who need them the most.
(Ames, et al., 2017) reiterated the fact that how and by whom communication is done, 
matters. When HCWs give parents information about immunisation in a respectful and 
caring manner, parents are more likely to bring their children for vaccination. 
Another approach to addressing knowledge deficiencies and inaccuracies is through social 
mobilisation. In the  (Lukusa, Ndze, Mbeye, & Wiysonge, 2018) assessment of the effects 
of educating parents about immunisation in community settings and health facilities, the 
study found that this intervention improves vaccination coverage in LMICs regardless of 
whether it is in the community or at the facility. A review by (Lewin, et al., 2010) shows that 
there is moderate certainty of evidence that involving lay health workers in the community 
mobilisation process can increase the number of children adhering to their vaccination 
schedules. Lay health workers include community health workers, village health workers 
and treatment supporters. Rwanda’s impact of mHealth technologies for the uptake of 
services other than vaccination has been shown to be enhanced when operated by well-
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trained lay health workers (Ruton, et al., 2018); see (Text Box 1). (Nelson, Wallace, Sodha, 
Daniels,, & Dietz, 2016) showed that home-to-home social mobilisers could improve planning 
and monitoring by conducting a ‘census’ of children eligible for vaccination, identifying 
areas with many un-immunised children and referring people to health facilities for other 
basic health services. In LMICs, despite the documented positive impact of this strategy on 
coverage, social mobilisation efforts have been more focused during campaigns and not 
frequently used to promote routing immunisation. This was related to lack of funding for it in 
routine immunisation budgets (Jalloh, Wilhelm, Abad, & Prybylski, 2020).
(Saeterdal, Lewin, Austvoll-Dahlgren, Glenton, & Munabi-Babigumira, 2014), in their 
assessment of impact of communication interventions on vaccination uptake, concluded 
that the evidence supporting communication interventions to change pre-conceived 
attitudes in favour of vaccinating among parents with young children is weak. (Oku, et 
al., 2017) also argued that although several studies have suggested that regular exposure 
through mass media and community channels is key to promoting vaccination, the 
evidence on the effects of such community-aimed interventions to inform and educate 
about childhood vaccination is still quite weak. The engagement of traditional and religious 
institutions was seen to facilitate the delivery of communication for childhood vaccination, 
and particularly so in areas where resistant families and communities were commonly 
found; since these institutions were trusted and respected in many communities. However, 
an evaluation of the impact of this strategy on actual child immunisation uptake was found 
to be lacking. In their view there is persistent under-prioritisation of the communication 
aspect in immunisation programming, health workforce training and allocation, as well as 
budgeting. 
(Oku, et al., 2017) recommended that training of health workers needs to strongly address 
interpersonal communication skills, so that health workers can maximise any opportunities 
for reinforcement on immunisation and child health more generally. Such training can 
help to ensure that health workers provide relevant and comprehensible information in a 
respectful and culturally sensitive manner. (Brown, Oluwatosin, & Ogundeji, 2017) showed 
that a training intervention on immunisation for primary healthcare providers improved 
their knowledge and self-reported practice but did not improve their actual practice 
of communication with mothers on immunisation. The (Pantoja, et al., 2017) systematic 
review assessed strategies targeted at healthcare workers by offering education materials, 
internet-based learning, educational meetings and workshops, feedback, and reminders. 
Findings of the review showed that printed educational materials slightly improved practice 
outcomes among healthcare providers when used alone and compared to no intervention. 
Combined interactive and didactic (lecture-based) educational meetings were slightly 
more effective than didactic educational meetings alone. 
However,  (Ames, et al., 2017) shows that there is insufficient evidence to determine which 
training strategies are more likely to be effective for improving immunisation uptake.  (Oyo-
Ita, et al., 2016) found that health education (evidence-based discussions, distribution of 
posters and leaflets, information campaigns) compared to usual care, may increase the 
uptake of routine childhood vaccination (low- to moderate-certainty evidence) while 
training of immunisation managers to provide supervision to healthcare providers had low-
certainty evidence for effectiveness in improving vaccination coverage. 
The 2014 SAGE review on strategies for addressing vaccine hesitancy high-lighted the need 
to use strategies that are multi-component (seeking to address primary determinants), 
but it was noted that these must be accompanied by evaluation processes. Secondly, 
researching, identifying and understanding the issues of target audiences is critical. A third 
approach suggested is dialogue-based social mobilisation − for example, dialogue with 
the community, religious and traditional leaders and approaches/interventions that are 
in line with community processes  (SAGE, 2014)). The review highlighted that the use of 
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social mobilisation interventions for polio vaccinations were successful due to their design 
and application targeting population groups that were refusing the vaccines (SAGE, 2014). 
This approach could possibly be applied for other vaccines. Literature that informed these 
recommendations was from studies outside SSA as no regional specific studies had been 
done. 
3.2.4 Conclusions on knowledge deficiencies and inaccuracies as a root cause 
for low coverage and under-immunisation
1. Lack of knowledge regarding the benefits of immunisation, and the prevalence of 
misconceptions about vaccination effects among caregivers and community leaders, 
is one of the greatest root causes of low coverage and under-immunisation in SSA. 
2. This ignorance is commonly found in under-privileged community groups including 
younger mothers, illiterate and unschooled caregivers, people living in disadvantaged 
regions within a country, people with no history of contact with health facilities, and 
migrant and refugee communities, among others.
3. Vaccine hesitancy is a growing trend in SSA driven by fears of side effects fueled by 
ignorance and false information circulated in media, presenting a serious threat to efforts 
to increase immunisation coverage in the region. Region-specific studies on interventions 
against vaccine-hesitancy are lacking.
4. HCW are key resources for immunisation service provision as well as providers of accurate 
immunisation information for care givers and community leaders in their jurisdictions. 
However, the capacity of HCW to effectively deliver on these mandates is, in many 
instances, limited by their own knowledge deficiencies regarding vaccines and vaccine 
effects, immunisation policies, identification of un- and under-immunised children, social 
mobilisation and counselling skills, and data management. This limitation is attributed to 
lack of adequate pre- and in-service training underpinned by limited political investment 
in this area.
5. Various communication and social mobilisation strategies have been deployed to 
encourage immunisation uptake in SSA with various degrees of success. However, these 
efforts are mostly focused around supplemental immunisation campaigns and under-
prioritised in resource allocation in routine immunisation budgets. Additionally, impact 
evaluation research of the different strategies on vaccination uptake is inadequate, 
with minimal literature coming particularly from the Central African region.
3.2.5 Recommendations on knowledge deficiencies and inaccuracies as a root 
cause for low coverage and under-immunisation
1. Funders and managers of immunisation programmes should aim to maintain a balance 
between investment in the essential components of an immunisation system (resources 
that enable programme readiness) and work force capacity to design and execute 
implementation strategies. This includes deployment and recurrent training of HCW 
to fully comprehend vaccines and their effects, the immunisation support practices 
and policies, and the community needs and desires. This will empower them to tailor 
appropriate communication and social mobilisation strategies to address knowledge 
deficiencies and inaccuracies among caregivers and community leaders.
2. Researchers in SSA should address evidence gaps in the areas of impact evaluations 
of the various communication and social mobilisation techniques employed to address 
knowledge deficiencies and inaccuracies regarding immunisation. This will provide the 
evidence base needed by policy and decision makers to select the most appropriate 
options for the various settings in the region. Special consideration should be made in 
Central African countries where evidence gaps are pervasive.
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 Rwanda, which has maintained one of the highest vaccination coverage rates in 
SSA, utilises two mobile health (mHealth) technologies, namely the RapidSMS and 
the mUbuzima applications (World Health Organisation, 2013). RapidSMS is a text-
messaging tool used by community health workers to conduct routine surveillance of 
health events during the course of a woman’s pregnancy, delivery, and for the first 
year of the infant’s life. mUbuzima, on the other hand, uses interactive voice response 
technology to enable community health worker team leaders in each village to 
submit data on a monthly basis relating to indicators for case management of sick 
children, nutritional status, vaccinations, supervision, maternal health and deaths at 
home (World Health Organisation, 2013). Since vaccination coverage in Rwanda was 
already very high when the impact of RapidSMS was evaluated, this “ceiling effect” 
made it difficult to evaluate its impact on vaccination uptake (Hategeka, Ruton, & 
Law, 2019). However, both tools are assumed to have contributed in sustaining the 
country’s high vaccination coverage levels.     
 
  Rwanda’s RapidSMS and mUbuzima technologies 
 Source: WHO 2013  https://apps.who.int/iris/bitstream/handle/10665/92814/WHO_RHR_13.15_eng.
pdf?sequence=1
 South Africa has also implemented communication interventions which include 
MomConnect. MomConnect is a free for mobile phone-based information and 
messaging service, which is a project of the National Department of Health. This 
service supports maternal and child health through integrating mHealth technology 
into maternal and child health services, from pregnancy to when the child is one-
year-old. One of the objectives of the service is to send targeted health promotion 
messages to pregnant women to improve their health and that of their infants, and 
this includes vaccinations (Department of Health, Republic of South Africa, 2019). In 
a study investigating the impact, it was found that MomConnect users had a slightly 
higher complete EPI attendance record compared to non-users. Furthermore, 98.2% 
of users said the messages they received helped them make better maternal and 
infant health decisions (Coleman & Xiong, 2017).
3.3 Trust – relationships and allegiances
Trust is important when there is an implicit imbalance of power due to a high level of 
information asymmetry, where trusting individuals accept a vulnerable position in relation 
to a trusted party. In the context of vaccine decisions, one chooses to trust another to help 
make a risk/benefit-based decision about which one has incomplete information. Lack 
of trust in vaccines and in the health-system has been identified as an important barrier 
in some settings, preventing children from receiving life-saving immunisations (Ozawa & 
Stack, 2013). Trust in vaccines and in the health-system is an important element of public 
health programmes that aim to deliver life-saving vaccines. Indeed, understanding the 
RapidSMS
CHWs report client health events 
(up to 1 year after delivery) and receive 
actionable responses; health facilities 
are notied to prepare for delivery 
or provide ambulance
mUbuzima
CHW team leaders use IVR technology 
to report monthly data on health 
indicators for women and children
mHealth allows for real-time 
decision-making and 
contributes to national 
monitoring of MDG indicators
Clients receive the 
care they need
CHWs visit pregnant women, new mothers 
and children, and use mHealth to send 
data and receive support
3. Text Box 1: Country experiences of mHealth for Immunisation
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contributors and threats to trust is essential to explaining vaccine acceptance. Vaccine 
acceptance involves multiple levels of trust: trust in the product (the vaccine), the provider 
(specific healthcare professionals or administrative staff that are involved in providing and 
administering vaccination), and trust in policymakers (the health-system, government, 
public health researchers involved in approving and recommending the vaccine) (Larson, 
et al., 2018). In a trust index survey done in different countries including Nigeria, it was found 
that confidence issues were the primary driver of hesitancy (Larson, Schulz, Tucker, & Smith, 
2015).
3.3.1 Demand-side trust issues
A systematic review of barriers to childhood immunisation in SSA noted that parents held 
reservations towards the associated side effects of vaccines (Bangura J. B., 2020). Others 
expressed a total distrust of immunisation programmes and vaccines. The review noted that 
this was in line with a previous review of influenza vaccine hesitancy, which pointed out that 
a lack of confidence due to low perceived effectiveness of the vaccine was a hindrance 
to vaccine uptake. (Bangura J. B., 2020) cited a 2018 systematic review that outlined similar 
beliefs, including concerns about side effects, scepticism toward vaccine safety, and belief 
in conspiracy theories.
Socio-cultural ties, including religious and cultural affiliations, have been cited as reasons 
for parents to avoid childhood vaccination. Where immunisation practices conflict with 
religious or cultural beliefs, allegiance to one’s affiliation may deter uptake of immunisation 
services. Weddings and funerals in some countries last up to a week and result in mothers 
missing vaccination appointments  (Favin, Steinglass, Fields, Banerjee, & Sawhney, 2012). 
Certain religions and cultures encourage parents to use alternatives to vaccination. 
Religious objections to vaccines are generally based on a few assumptions, the first being 
that some vaccines are created using human tissue cells and secondly the belief that the 
body is sacred and should be healed by God or by natural herbs (Ozawa, Zhou, Wonodi, 
Chen, & Bridges, 2018). A qualitative study of apostolic communities in Zimbabwe reported 
that accepting vaccination services in public introduced the risk of social sanctions by the 
community, which contributed to clustering of under-immunisation. 
Statements about sticking to one’s own culture and religious beliefs are ranked to be more 
important than perceived benefits and risks, healthcare service, vaccine information, or 
opportunity costs (Ozawa, Zhou, Wonodi, Chen, & Bridges, 2018). In some traditional cultures, 
families refuse to take the baby out for vaccination during a period of post-partum seclusion 
(Favin, Steinglass, Fields, Banerjee, & Sawhney, 2012). A study using best-worst scaling to 
rank factors contributing to vaccine hesitancy in northern Nigeria reported that men ranked 
the views of their leaders and the media as most influential on their behaviour, whilst women 
placed greater emphasis on social perceptions and norms (Ozawa, Zhou, Wonodi, Chen, 
& Bridges, 2018). 
Studies on vaccine hesitancy in SSA note that although HCW are essential sources of 
information to reduce hesitancy, some caregivers do not trust the healthcare system and 
frequently feel intimidated. (Costa C. J., Weber, Darmstadt, Abdalla, & Victora, 2020) studied 
the relationship between religious affiliation and immunisation coverage in 15 countries in 
SSA and found that Muslim communities were associated with lower vaccine coverage in 
several SSA countries even after removal of confounding factors. (Olurunsaiye & Degge, 
2016) in their multilevel analysis of the socioeconomic determinants of spatial variations in 
child immunisation among states in Nigeria also found similar patterns among Muslims, but 
this was attributed to political and socio-economic climates that caused Muslims to mistrust 
the healthcare system, an assertion also made by (Obadare E. , 2005) when reviewing the 
polio vaccine boycott in Northern Nigeria.
3.3.2 Supply-side trust issues
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Mistrust of the healthcare system is another cause for under-immunisation in SSA. Studies on 
vaccine hesitancy in SSA note that although healthcare workers are essential sources of 
information to reduce hesitancy, some caregivers do not trust the healthcare system, and 
frequently feel intimidated due to the unwelcoming behaviour of HCW during immunisation 
visits (Handy, et al., 2017), (Cabos Munoz, Monzon Llamas, & Bosch-Capblanch, 2015). Mothers 
who have demonstrated trust in the healthcare system indicated by history of contact with 
HCW through antenatal and post-natal visits and health facility births often have higher 
chances of having their infants fully immunised  (Tamirat & Sisay, 2019). (Costa J. C., Weber, 
Darmstadt, Abdalla, & Victoria, 2019) studied the relationship between religious affiliation 
and immunisation coverage in 15 countries in SSA and found that Muslim communities were 
associated with lower vaccine coverage in several SSA countries even after removal of 
confounding factors. However, (Olurunsaiye & Degge, 2016) in their multilevel analysis of 
the socioeconomic determinants of spatial variations in child immunisation among states 
in Nigeria found similar patterns among Muslims, although this was attributed to political 
and socio-economic climates that caused Muslims to mistrust the healthcare system, an 
assertion also made by (Obadare E. , 2005) when reviewing the polio boycott in Northern 
Nigeria.
3.3.3 Interventions to build trust in immunisation programmes
UNICEF analysed case studies of efforts in two SSA countries to build trust in immunisation, 
addressing religious groups. It documented lessons learnt from Sierra Leone, where after 
just two years of activity, the immunisation programme reached its goal, moving from 6% 
to 75% coverage of Sierra Leone’s children under one year of age (UNICEF, 2004). The take 
home messages from this were the importance of training HCWs to acquire the necessary 
skills for social mobilisation (25% of the budget was allocated to training), engagement 
with respected leaders of communities and facilitating them to act as change agents in a 
contextualised approach, thus forging ownership for the programme, and having flexibility 
in programming that allows for monitoring, evaluation and learning during implementation. 
In Angola, a country that had been embroiled in decades of civil war and with resistance 
to immunisation by church leaders, the approach used for garnering trust for the polio 
vaccination was a combination of building alliances through identification of shared 
philosophical goals, contextualised messaging though mass media and partnerships 
between community groups and HCWs for outreach services (UNICEF, 2004).
(LaFond, et al., 2015), in their assessment of drivers of improved immunisation coverage in 
Africa covering case studies from Ethiopia, Cameroon, and Ghana, found that proximity of 
HCWs through community-centred health workers and through their routine interaction with 
communities, built a familiarity and sense of trust among the community who referred to 
them for information on immunisation. The outcome was increased access to immunisation 
and increased use. Close co-operation between the health sector and the administrative 
and political structures at the district and community level was also successful. These groups 
jointly planned services, raised awareness, reviewed performance and defined strategies to 
reach remote or reluctant communities. Through these partnership mechanisms, the health 
system, community leaders and volunteers developed a shared sense of purpose and built 
credibility for immunisation. The effect of this driver was greater regularity and predictability 
of service delivery and improved respect for health workers for maintaining the service 
delivery schedule (LaFond, et al., 2015).
In an effort to improve confidence in immunisation policymakers, the GVAP set out a 
2020 target for all countries to setup, or have access to, National Immunisation Technical 
Advisory Groups (NITAGs), which are meant to promote country ownership of immunisation 
programmes through the review of factors such as local epidemiology and resource 
availability (Duclos, 2010). NITAGs are multi-disciplinary bodies of national experts whose 
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goal is to give impartial, evidence-based recommendations that will guide vaccination 
and decision-making by policymakers and programme managers (Duclos 2010).   (Wiyeh, 
Sambala, Ngcobo, & Wiysonge, 2018) showed that the number of NITAGs in the WHO African 
Region increased from 15 (28%) in 2010 to 26 (48%) in 2016 while the number of functional 
ones, based on the six process indicators (Text Box 2) also increased from 5 (9%) in 2010 to 16 
(30%) in 2016. Of the SSA countries analysed, (Wiyeh, Sambala, Ngcobo, & Wiysonge, 2018) 
found that between 2010 and 2016, only Cote d’Ivoire had a functional NITAG consistently 
throughout while all the other countries fluctuated.
Text Box 2: NITAG six process indicators 
NITAG six process indicators (Bell, Blanchard, Walls, Mounier-Jack, & Howard, 2019):
1. Legislative or administrative basis 
2. Formal written terms of reference 
3. Membership expertise
4. At least one annual meeting
5. Agenda and background documents available to members at least a week before 
a meeting 
6. Members to declare conflict of interest
Between 2008 and 2017, the Supporting Independent Immunisation and Vaccine Advisory 
Committee (SIVAC) initiative provided advocacy and support, partnership development, 
and strengthening and capacity development to NITAGs.  (Bell, Blanchard, Walls, Mounier-
Jack, & Howard, 2019) utilised the data from the SIVAC evaluation to examine NITAGs role 
and value, contributing factors to their effectiveness and challenges to global investment in 
them. With regards to effectiveness, the study found that this remains a challenge especially 
for recently established NITAGs. Challenges include imbalance of expertise, understaffed 
secretariats, conflict of interest management and unsustainable funding  (Bell, Blanchard, 
Walls, Mounier-Jack, & Howard, 2019). 
A systematic review conducted by (Larson, et al., 2018), looking at the impact of interventions 
deployed to garner trust in the immunisation programme, found no literature from SSA on 
the topic.
3.3.4 Conclusions on trust
1. Trust in the overall health care system directly impacts on the trust in the immunisation 
programme in SSA. The conduct of HCW during health-seeking visits, and the com-
munity’s perceptions of the political and socio-economic climates affect individual and 
community group trust relationships with the healthcare system.
2. Socio-cultural ties and influences, including culture and religion, play a significant role in 
decisions regarding uptake of vaccinations and are primary causes of hesitancy in SSA.
3. While some measures of success have been demonstrated in the application of various 
trust building strategies − including training of HCWs, use of community change agents, 
building alliances and partnerships in a contextualised approach, and establishment 
of NITAGs − there is a consistent lack of a systematic evaluation of the impact of these 
approaches on the uptake of immunisation in SSA.
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3.3.5 Recommendations on trust
1. Political and socio-economic leaders should be cognisant in their actions of the sensitivity 
of the immunisation programme to overall confidence in the healthcare system. Actions 
that engender trust and confidence in the healthcare systems should be promoted.
2. Researchers should conduct longitudinal studies evaluating the impact of different trust 
building interventions on the uptake of immunisation in SSA over time, using defined and 
uniform indicators in order to increase comparability. These would then benefit decision-
makers to guide policy creation based on sound scientific evidence.
3.4 Convenience – access and reliability
Convenience in this case refers to ease of access to and delivery of timely and reliable 
immunisation services.
3.4.1 Demand-side convenience issues
Caregiver access to immunisation services is hindered in two ways: distance and time. 
Bangura et al. (2020), in their systematic review, cited several studies that indicated that 
families who needed longer travel times to access health care services, were more likely 
to not have their children vaccinated, with one study positing that “families whose home 
was at least an hour from the vaccination site were less likely to be fully vaccinated 
(56%) than families whose home was between 30 and 59 min away (67%)” (Tefera, et al., 
2018). Geographic isolation, where populations are separated by physical barriers such 
as mountain ranges, rivers, lakes, or deserts, has been identified as one of the barriers to 
caregivers accessing health centres. Geographic barriers also include climatic, social, and 
economic characteristics that cluster geographically then lead to a spatial distribution of 
health inequity  (Yourkavitch, Burgert-Bruker, Assaf, & Delgado, 2018). Both WHO and UNICEF 
have acknowledged the association between geographic isolation and inequitable access 
to vaccine interventions  (WHO, 2015), (Chopra, Sharkey, Dalmiya, Anthony, & Binkin, 2012). 
The remoteness of communities makes it more challenging for healthcare workers to reach 
those locations and it is unlikely that community members will seek vaccination services 
((Mbegue, et al., 2017), (Okwaraji, Cousens, Berhane, Mulholland, & Edmond, 2012), (Sally 
& Kenu, 2017). 
In terms of time, parents who are employed stated that the waiting time at the clinic affects 
their adherence to vaccination schedule because vaccination could easily take one day 
in rural areas and they would lose potential income for the day  (Antai, 2011), (Babirye, et 
al., 2012), (Chidiebere, Uchenna, & Kenechi, 2014). The type of employment matters too, 
(Bbaale, 2013) found that children whose parents were in agriculture or blue collar jobs 
were less likely to be fully immunised than those whose parents had white collar jobs in 
Uganda. (Tefera, et al., 2018) found that  housewives had children with higher coverage 
of full immunisation status (63%) than certain other occupations such as merchants (51%) 
or public/private employees (56%), with mothers of incompletely vaccinated children 
identifying lack of time as one of the reasons.  (Zewdie, Letebo, & Mekonnen, 2016) cited 
the high workload of women and lack of support from their partners as a reason for children 
missing immunisation in South Africa.
 
3.4.2 Supply-side convenience issues
Bangura et al. (2020) found the following health system barriers to have affected immunisation 
uptake: broken cold-chain, irregular supplies and distribution of vaccines, limited human 
resources and infrastructure, long distances separating health facilities from families, and 
vaccine shortages at health facility level.
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According to a 2017 global stock out assessment report, the incidence of national-level 
stock-outs is most pronounced in the WHO African region where 38% of countries were 
affected (Lydon, et al., 2017). At the national level, procurement challenges are the leading 
cause of vaccine stock-outs. Most Gavi eligible countries in SSA procure their vaccines 
through UNICEF. A root cause analysis of national stock-outs in 90 UNICEF procuring countries 
(2011 - 2015) showed that funding delays account for 39%, while poor forecasting and stock 
management are at 23%, procurement delays at 18%, and global shortage at 9% (Lydon, et 
al., 2017).  (WHO, 2017) findings concur that stock-outs in Gavi-eligible countries are primarily 
due to global shortages, inaccurate forecasts or stock management issues and funding 
delays as shown in Figure 10.
Once the vaccines are procured, the next challenge is in storage and transportation. 
Thermal stability (the need to continually keep vaccines in a 2°C to 8°C cold chain) is a 
major constraining factor in vaccine storage and in the “last mile delivery” from health 
centres to vaccination site (Zipursky, et al., 2014). Gavi estimates that half of the healthcare 
facilities in the poorest countries have no electricity supply at all, with only 10% having a 
reliable electricity supply to maintain a cold chain  (GAVI, 2013).
 
Figure	10:	Causes	of	national	stock-outs	adjusted	by	income	group,	2016
Source: WHO 2017 
A study by (Vouking, et al., 2019) found that, with several exceptions, iSCs in SSA face chronic 
difficulties in providing uninterrupted availability of potent vaccines up to service delivery 
levels, and many government-managed systems remained crippled by inefficiencies in 
vaccine storage, distribution, vaccine management and stock control. These observations 
were consistent with earlier reports  (Ashok, Brison, & LeTallec, 2017), (Mihigo, Okeibunor, 
Anya, Mkanda, & Zawaira, 2017). A 2016 Gavi annual report similarly showed that three in 
four African countries lacked adequate systems for proper vaccine handling, leading to 
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A (Mbegue, et al., 2017) study conducted in Senegal highlighted that one of the causes 
of low vaccination coverage is logistical challenges in moving vaccines between regions. 
The regions that have sufficient resources are unable to supply resources to regions that are 
lacking. The study showed that delivering vaccine services to Senegal’s sparsely populated 
and arid eastern regions was a difficult logistical challenge, resulting in lower-than-average 
vaccination coverage rates. Similarly, survey data from Kwahu Afram Plains North, an island 
district in eastern Ghana, showed that vaccination coverage was worse in sub-districts that 
are “islands of an island” and those communities isolated by difficult terrain showed by far 
the lowest vaccination coverage rates (Sally & Kenu, 2017). (Akoh, et al., 2016)  in a cross-
sectional study in rural Cameroon, argued that vaccination teams may be deterred from 
visiting or revisiting remote communities because they cannot afford simple needs such as 
fuel for transportation. 
(Lydon, et al., Vaccine stockouts around the world: Are essential vaccines always available 
when needed?, 2017) demonstrated that national level stock-outs can have a ripple effect, 
resulting in district level and health facility level stock outs and interrupted immunisation 
service delivery at facility level. (Burnett, et al., 2018), used a hospital-based survey in 
South Africa to make an analysis of the impact of stock-outs at health facilities on national 
vaccination coverage, and found that almost 45% of children eligible to have received 
all the vaccines offered in the first year of life were found to be under-vaccinated, with 
the vast majority of them being affected by stock-outs of the vaccines. While there were 
inferences that this was a result of national level stock-out, deeper analysis suggested that 
these were caused by human error, resulting in poor stock management occurring either at 
district or facility level.
(Steele, 2014) in a systematic review to understand the underlying drivers to the iSC 
challenges in SSA found the following underlying causes:
1. Lack of professionalisation where iSC functions are frequently performed by untrained 
healthcare workers such as pharmacists, clinicians and drivers.  
2. Lack of training and the available training is often too rigid, distributed in a 
geographically uneven way, and does not prepare individuals to connect and 
coordinate with the key institutions.
3. Poor availability of accurate national data to enable accurate needs forecasting. 
A misunderstanding of the importance of SCM in relation to global health resulting in 
under-prioritisation. 
4. Rigid supply chain management systems that have not responded adequately to 
meet new demands arising from issues of demographic and epidemiological change 
and the influx of new vaccines. 
5. Lack of performance incentives to support professionalisation, accountability, and 
transparency.
6. Poor supply chain practices including poor monitoring systems. 
(Steele, 2014) concludes that poor knowledge of both vaccines and the supply chain 
practises are causal factors of vaccine wastage and stock-outs. Vaccine wastage was 
cited as a cause for insufficient availability of vaccines in health facilities resulting in missed 
opportunities for vaccination by (Adamu, et al., 2019). Conversely, (Usuf, 2018) in a study 
on vaccine wastage in health facilities in Gambia, found that although there were some 
incidences of vaccine wastage, the levels of it did not significantly impact vaccine availability 
and overall vaccination uptake. Wastage was observed mainly through unused doses at 
the end of vaccination sessions. Wastage from the liquid vaccines multi-dose/single-dose 
vials were very minimal, with peaks due to expiry or breakage of the vaccine diluent (Usuf, 
2018). Overall, expiration and breakage were found to be the main reasons for the vaccine 
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wastage from cold rooms. The study also interviewed 80 health workers and observed good 
knowledge about vaccine wastage. (Wallace, et al., 2017) undertook a study in Nigeria 
where they assessed vaccine wastage rates, related vaccinator knowledge, attitudes and 
practices in 54 health facilities. The study found that almost half of the facilities surveyed had 
incomplete vaccine stock data for calculating vaccine wastage rates and for those that 
had data, the average facility level wastage rates were between 18% and 35% with minor 
differences between lyophilised and liquid vaccines. 
(Stokes-Prindle, undated) and (Lee, et al., 2010) argue that the single and multi-dose vial 
selections can have both negative and positive impacts on vaccination coverage and 
the “best” container choice will vary by context. For example, if vaccine wastage is not 
a significant problem, the vaccine is relatively inexpensive, disposing of medical waste 
is difficult and cold-chain storage capacity is constrained, multi-dose vials may be more 
favourable. (Usuf, 2018) cited a review by UNICEF on the cost-effectiveness of changing 
from a 20-dose vial to a 10-dose vial of BCG which concluded that it might be more cost-
effective to waste vaccines than to reduce the vial size as the price difference was only 2% to 
8%.  Conversely, if the vaccine is expensive, vaccine contamination risk is high, and patients 
visit the clinic with irregular frequency, single-dose formats may be more appropriate.
On the challenges attributed to human resources for health, a study by (Oku, et al., 2017) 
on vaccine perceptions in Nigeria found that poor communication skills, unpleasant 
attitudes, and lack of motivation among health workers played major roles in creating 
negative perceptions on vaccines among caregivers. (Favin, Steinglass, Fields, Banerjee, & 
Sawhney, 2012) reported that caregivers identified the health clinic environment, with long 
waiting times and poor health worker attitudes, as a major barrier to receiving vaccination 
information. (Chadambuka, et al., 2012) attributed these immunisation health worker 
challenges to inexperience, lack of sufficient training and work overload. As there were 
few healthcare providers available for immunisation services, shortages had a snowball 
effect resulting in unreliable communication channels and registers getting lost, hindering 
effective follow-ups. The majority of SSA countries fall below the WHO recommended 
threshold of 4.45 doctors, nurses and midwives per 1,000 population. (Pozo-Martin, Noye, 
& Lopes, 2017) (Wiysonge, Uthman, Ndumbe, & Hussey, 2012) identified factors such as 
insufficient knowledge of immunisation among staff, staff shortages, high staff turnover, 
financial constraints, poor communication among stakeholders and poor collaboration 
between the public and private health sectors as negative influencers to immunisation.
3.4.3 Interventions to improve convenience
To address demand-side convenience issues some interventions have been implemented, 
such as increasing the number of immunisation posts closer to hard-to-reach communities 
and outreach services. Outreach services have been used with positive impact on 
immunisation coverage by reaching underserved communities in SSA countries such 
as  Uganda, Ethiopia, Cameroon, DRC, Togo, Cameroon, Malawi, Kenya, Madagascar, 
Zimbabwe, Angola and Zambia (Ryman, et al., 2010), (Sasaki, et al., 2011), (Nsubuga, et 
al., 2019), (JSI, 2012). Outreach services have particularly been beneficial in increasing 
immunisation coverage in refugee settlements in Uganda (Makumbi C. N., 2017). Outreach 
was found to be particularly successful where optimal location of health posts and timing 
of service delivery were well informed and contextualised to the targeted community 
(LaFond & Sequeira, 2012),  (Malande, et al., 2019), (JSI, 2012). Outreach is also a key part of 
the WHO/UNICEF Reaching Every District/Reaching Every Child community level approach. 
Other outreach methods include supportive supervision, on-site training, community links with 
service delivery, monitoring and use of data for action, better planning and management of 
human and financial resources (Vandelaer, Bilous, & Nshimirimana, 2008).  However, despite 
the promising nature of this model in SSA, its implementation is not fully optimised in some 
areas due to healthcare worker ignorance of model, lack of resources, and poor linkages 
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with communities (Ryman, et al., 2010), (Muchekeza, Chimusoro, Ncube, & Pomerai, 2014). 
On the supply side, two areas have been targeted: human resource constrains and 
immunisation supply chain challenges.
Addressing human resource constraints, optimising the roles of less specialised health 
workers − lay health workers, community health workers, village health workers and 
treatment supporters − “task shifting” has been used to address the shortage and mal-
distribution of more specialised health professionals, and has been found to have some 
positive impacts in improving maternal and child care outcomes including immunisation 
completion (Nabudere, Asiimwe, & Mijumbi, 2011).  (LaFond & Sequeira, 2012) found that 
recruiting locally and supporting health extension workers through local administration 
units had a significant impact on increasing immunisation coverage in previously poorly 
performing regions in Ethiopia. (Lewin, et al., 2010) showed that there is moderate certainty 
of evidence that involving these cadre of workers in the immunisation process, for example 
by using them as a source for providing information about immunisation to communities 
and identifying unimmunised children, can increase the number of children adhering to 
their vaccination schedules.  A systematic review by (Oyo-Ita, et al., 2016) also showed that 
home visits by these cadres of workers can also increase childhood vaccination coverage 
in LMICs. 
Task shifting has also been used in cold chain maintenance, a specialist area chronically 
short of skilled workers in SSA (Bangura, et al., 2020). In Mozambique task shifting was 
successfully used to solve the problem of maintaining the cold-chain system through training 
of field coordinators, who are responsible for distribution of vaccines and data collection, 
to also perform some basic preventive maintenance tasks during their distribution visits. This 
resulted in increased up time of the cold chain in participating districts averaging at 95% 
(VillageReach, 2014). WHO stresses that task shifting should be implemented alongside 
other strategies and interventions that are intended to increase the numbers of health 
workers (WHO, 2018). This is in line with the findings of (Anand & Bärnighausen, 2007), which 
showed that a higher density of nurses in developing countries increases the availability 
of vaccination services over time and space, making it more likely that children will be 
vaccinated.
Some studies go as far as suggesting performance rewards, which would require effective 
performance management systems in the health sector all the way down to the service 
delivery point (Favin, Steinglass, Fields, Banerjee, & Sawhney, 2012) (Lutwama, Roos, & 
Dolamo, 2013), in their district level assessment in Uganda including research from other 
SSA countries, found varying levels of performance management implementation − poorly 
implemented systems or none at all in Mali, Benin and Malawi and relatively strong systems in 
Kenya and Uganda. (LaFond & Sequeira, 2012), in a sub-national level study in Ethiopia, found 
some positive outcomes from using accountability and incentives to stimulate competition 
and motivate health managers and government administrators at the community level − a 
setting where strong emphasis is placed on measuring and openly reporting on progress in 
health care, including immunisation.
On addressing immunisation supply chain challenges, strategies to minimise stock- outs and 
strengthen cold chain systems have been applied. A review of interventions for vaccine 
stock management in primary health-care facilities suggested that the use of digital 
information systems to improve information and stock visibility has the potential to increase 
vaccine availability, reduce response times, and improve the quality of vaccine records 
(Iwu, Jaca, Abdullahi, Ngcobo, & Wiysonge, 2019).
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(Lydon, et al., 2017) suggest the following interventions to address procurement delays at 
the national level:
1. Addressing delays in releasing national funds to purchase vaccines on time and ensure 
vaccine financing.
2. Improving forecasting accuracy, stock management practices and data systems for 
managing vaccines.
3. Addressing cumbersome national procurement processes and delays, especially in 
self-procuring countries.  
UNICEF introduced a Vaccine Independence Initiative (VII) which is a financial mechanism 
designed to bridge temporary gaps when domestic budgets are not immediately available 
at the time of procurement. The goal is to provide short-term loans to countries and support 
timely procurement and reduce stock-outs. By 2015, five SSA countries had signed up for VII, 
namely Chad, Cape Verde, Cote d’Ivoire, Kenya and Nigeria. In December 2017, UNICEF 
announced a doubling in this fund to $35 million (UNICEF, 2017).
In 2019, nine middle-income countries in Africa not eligible for immunisation financing support 
from Gavi, the Vaccine Alliance − including Algeria, Botswana, Cabo Verde, Kingdom of 
Eswatini, Gabon, Mauritius, Namibia, São Tomé and Príncipe and Seychelles − agreed to 
work towards pooled procurement mechanisms. They argued that sharing information and 
ultimately pooling their orders would better leverage their individual purchasing power and 
thus strengthen their vaccine security and increase their access to affordable life-saving 
vaccines (WHO, 2019). (Seidman & Atun, 2017) in a systematic review, found no evidence to 
suggest that centralised procurement and tendering in LMICs resulted in reduced stock-outs 
or increased availability of pharmaceutical products, although most references indicated 
cost savings.   
In 2015, global shortages of meningococcal vaccine threatened efforts to manage an 
outbreak of meningitis in Niger resulting in a large meningitis epidemic (Maurice, 2015).  A 
more directed vaccine manufacturing programme in Africa has been suggested as a means 
of addressing the challenge of global shortage and ensuing vaccine security for African 
countries (Mehta, Van Duyse, & Schmitt, 2017). Vaccine supply in Africa is almost entirely 
externally sourced with marginal manufacturing contributed by Senegal, Egypt, South 
Africa and Tunisia, with Ethiopia planning to contribute in the future (Ampofo, undated). In 
2010, the African Vaccine Manufacturing Initiative lobby group was created to coordinate 
efforts of African vaccine manufacturers and other interested parties who have a vision 
to see Africa produce its own vaccines and biologicals for both routine and emergency 
situations (AVMI, 2020). The anticipated challenges with manufacturing of vaccines in 
Africa include high cost as well as lack of infrastructure, human expertise and political will 
(Makenga, Bonoli, Montomoli, Carrier, & Auerbach, 2019). Despite these challenges, there 
are opportunities and indications of increasing interest in vaccine manufacturing in Africa 
from various stakeholders (Makenga, Bonoli, Montomoli, Carrier, & Auerbach, 2019). Of 
note, experiences from India show that local production is not a stand-alone solution to 
vaccine supply security but must be accompanied by complimentary strategies such as 
taking suitable (and transparent) measures to encourage the indigenous private sector, 
a strong disease surveillance system, and a strong emphasis on in-house research and 
development (Madhavi, 2005).  
The following innovations to overcome vaccine cold chain constraints have been suggested 
and implemented: 
1. Use of Controlled Temperature Chain (CTC) with vaccines that can withstand conditions 
outside the cold chain for a specified period, for example WHO pre-qualified CTC 
MenAfriVac, successfully used in a mass campaign in Chad, Cote D’Ivoire and Benin with 
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comparatively lower levels of confidence and success  (Zipursky, et al., 2014), (Kouassi, 
et al., 2016). CTC has also been recorded to have indirect benefits on cold chain costs, 
with the Chad study showing up to 50% reduction in remote areas (Zipursky, et al., 2014). 
However, the downside is the risk of wastage due to untrained workers not following CTC 
standard operating procedures (Kouassi, et al., 2016). 
2. Use of solar powered refrigerators (McCarney, Robertson, Arnaud, Lorenson, & Lloyd, 
2013).
3. Developing thermostable vaccines (Chen & Kristensen, 2009), (Kristensen, Lorenson, 
Bartholomew, & Villadiego, 2016).
It has been noted, however, that further development and uptake of some of these innovations 
is hampered by a lack of transparency on the part of vaccine manufacturers regarding the 
true limits of their vaccine products. There is also a lack of effective communication on the 
part of equipment manufacturers, particularly in challenges related to their application. 
Weak advocacy on the part of the consumers and immunisation development partners 
has been perceived to condone complacency on the part of industry (Comes, 2018), (MSF, 
2014). 
As part of GVAP, countries pledged to strengthen their iSC by 2020 through developing 
robust improvement plans, designing systems that improve efficiency, implementing 
improved data management using electronic systems to minimise stock-outs, optimising 
cold chain systems, and having dedicated iSC managers at national level (WHO, 2017). In 
2014, a team of Gavi partners (the Gavi Secretariat, WHO, UNICEF, and the Bill & Melinda 
Gates Foundation) formed the People and Practice Working Group that came together to 
identify the root causes of iSC failures and to propose strategies to overcome them (WHO, 
2017). 
Some SSA countries have piloted iSC system redesigns, the outcomes of which were 
subjected to systematic reviews (Vouking, et al., 2019), (Iwu, et al., 2020).  The Ministries of 
Health in Benin, Nigeria, Mozambique and South Africa undertook system redesign activities 
to address the longstanding underperforming iSC systems (Vouking, et al., 2019), (Iwu, 
Jaca, Abdullahi, Ngcobo, & Wiysonge, 2019), (Iwu, et al., 2020). In the intervention areas, 
a simulation-modelling tool was used to identify the most suitable design for improving 
the performance of iSC in terms of vaccine adequacy and availability, logistics, cost per 
dose administered, and vaccination coverage. The system redesigns were preceded 
by infrastructure and human resource remedies including stocking the right cold chain 
equipment and training personnel in iSC management. 
Benin’s redesign was done in 2013. Vaccine storage was consolidated from the sub-district 
to the district, and the delivery was transformed to an informed push model4 using delivery 
truck loops to deliver vaccines directly from the district store to the health facilities using 
real-time data from the health facilities, and delivery routes carefully planned to maximise 
health facility reach and truck storage space (Prosser, et al., 2017). A 2014 assessment of 
pilot district performance using the Effective Vaccine Management (EVM) criteria showed 
that pilot district scores were significantly higher than those in the control district in all criteria, 
with unmatched differences in distribution (100% versus 32%), vaccine management (94% 
versus 63%) and maintenance (79% versus 6%), (Prosser, et al., 2017), (Vouking, et al., 2019). 
In Mozambique, the alternative design eliminated the district level as a distribution point, 
which became a warehouse for emergency stock only. Deliveries were made monthly 
from the provincial level directly to the health facility using delivery loops designed to 
4 ‘Informed Push’ supply chain models (IPM): commodities are distributed to health clinics on a predetermined delivery 
schedule without first requiring an initiating order from clinics. Delivery trucks are loaded with quantities of commodities 
that anticipate specific needs, often based on data derived from previous usage and/or forecasting of near-future clinic 
needs
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take into account geographical terrain and population distribution patterns. At the end 
of the Mozambique five-year pilot in 2008, DTP3 coverage in children aged 12 - 23 months 
increased by nearly 24 points, rising from 68.9% in 2003 to 92.8% in 2008 compared to the 
control province that rose from 54.6% to 71.9%. Concurrently, drop-out rates between DTP1 
and DTP3 fell from 12% to 3.8%. Stock-out rates were reduced from 79% at baseline to less 
than 1% (Prosser, et al., 2017). 
In Nigeria’s pilot, which started in January 2013, stock holding levels at some local government 
areas in Kano state were eliminated. Instead, an informed push model, known as “PUSH 
Plus”, was recommended for testing in public health facilities in three government areas. 
Vaccine distribution to these facilities was outsourced to a private transporter, who, in turn, 
conducted bi-weekly deliveries of vaccines and vaccination consumables directly from the 
state cold store to the target facilities (Aina et al., 2017). After 20 months of implementation 
(in September 2016), stock adequacy improved from 54% to 68% and stock-out rates 
dropped from 41% to 10% (Aina, et al., 2017).
Anthropological studies showed improved frequency of vaccination services attributed to 
improved vaccine availability and staff time to care for patients (Vouking, et al., 2019). On 
the financial side, the cost-efficiencies found in these pilots suggest that system redesign 
can improve supply chain performance while reducing overall logistics costs (Vouking, 
et al., 2019). The systematic review also compared performance of in-house run versus 
outsourced-to-the-private-sector delivery systems. Results showed that in South Africa EVM 
scores for the “outsourced” iSC segments exceeded 80% as opposed to 63% in the segment 
managed “in-house”.
In Nigeria, with the private sector system, the percentage of facilities with vaccine stock-
outs dropped from 43% to 0%. At the same time, vaccination coverage in these facilities 
rose from 57% to 88%. (Molemodile, Wotogbe, & Abimbola, 2017) reviewed the same pilot in 
Kano State, Nigeria with the aim of understanding the underlying drivers of its success. Their 
findings attributed the success to improved ownership and accountability for immunisation 
by sub-national governments, and their improved capacity for generating resources and 
management of data and the supply chain. The successes of these iSC system redesigns 
notwithstanding, some challenges remain. Funding challenges, management capacity, 
and staff motivation at the federal and state levels remain impediments to sustained 
progress particularly as GAVI graduation is coinciding with a significant economic downturn 
(Sarley, et al., 2017). 
A systematic review (Seidman & Atun, 2017) looked at the changes in the supply chain 
system and its impact on drug and vaccine availability in LMICs (with 12 of 15 studies 
selected from SSA). The review found contrasting outcomes from the different supply chain 
models (for example the informed push used in Senegal and informed pull5 used in Uganda 
and Tanzania) with both achieving improved results. These results underscore the need for 
policymakers and programme managers to examine the root causes of inefficiencies in 
pharmaceutical supply chain and procurement processes in order to determine how best 
to improve health systems performance in their specific contexts.
3.4.4 Conclusions on convenience
1. Physical barriers that create longer travel times from communities to health facilities make 
it inconvenient for communities to access immunisation services and for health workers 
to deliver immunisation services to underserved communities. Socio-economic barriers, 
including heavy workloads and inflexible working environments (particularly for blue 
collar workers) and lack of family support, make it difficult for caregivers to take time off 
to access immunisation services. Considering that a majority of workers in SSA are blue 
5 commodities are distributed to health clinics by first requiring an initiating order from clinics. 
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collar and considering the large populations of displaced persons with no family support, 
there exists a significant challenge to immunisation service provision in the region.
2. Poor service delivery on the part of healthcare workers, exhibited as poor customer 
services, long waiting times, and inconsistent availability of immunisation services deter 
immunisation service uptake. Underlying this poor service delivery are systemic challenges 
such as heavy healthcare workloads due to low health-worker to population ratios, lack 
of motivation, poor remunerations and resulting high staff turn-over, and limitations within 
the immunisation supply chain.
3. Strategies deployed aimed at bringing immunisation services closer to communities 
through establishment of more community-based immunisation posts, conducting 
outreaches, task shifting, and use of community-based healthcare workers, have shown 
anecdotal improvements in immunisation coverage.  
4. Interventions aimed at improving vaccine security, including re-designs in the 
immunisation supply chains, use of controlled temperature chains, local manufacturing, 
and pooled financing and procurement mechanisms, though fairly recent, have 
been shown to have positive impacts on immunisation coverage based on early 
implementation stage assessments. However, a lack of comprehensive information 
on the part of the manufacturing industry has been identified as a challenge to the 
sustained implementation and scalability of these interventions.  
3.4.5 Recommendations on convenience
1. District level leadership should own and support the implementation of the WHO/UNICEF 
designed Reaching Every District/Reaching Every Child (RED/REC) strategy to reach 
every child with immunisation services implemented at the sub-national level through 
lobbying for sufficient fund allocation, progress monitoring, and supporting community 
engagement.
2. National level immunisation sector leadership should ensure that healthcare workers 
at service delivery points are sufficient (based on task requirements and populations 
served) and well-motivated. Innovations such as task shifting should be encouraged 
and supported at district levels through regular training, supervision and, where feasible, 
monetary compensation. Additionally, they should prioritise immunisation supply chain 
(iSC) management through capacity building of iSC experts and their involvement in top 
management decision making.
3. Regional level leadership, including WHO AFRO and African Union, should encourage 
national leaders to commit to the long-term vision of local vaccine manufacturing as 
a means to ensure sustainable vaccine supply for the region by putting in place the 
necessary foundational structures, including building local expertise, incentives for 
private sector investment, strengthening in-house research and development, and 
requisite infrastructure developments.
4. Immunisation development partners and Civil Society Organisations should incentivise 
and lobby for greater transparency from industry partners in order to support iSC 
innovations such as controlled temperature chains, and alternative energy sources.
5. Researchers should further study and evaluate impacts of innovations aimed at securing 
vaccine supply such as pooled procurement and longer-term implementation of 
immunisation supply chain re-designs on vaccination coverage.




African Academies of Sciences, in their joint publication on drivers to ensure African countries 
achieved globally agreed development agendas post-2015 era, ranked highly the issue of 
country ownership. They defined country ownership as leadership and participation — at all 
levels and in every sector of society — toward achieving a unified goal, where individuals 
have a stake in and a shared responsibility for delivering the common development agenda 
(UNAS, 2014). Country ownership is also one of the four effectiveness principles of the Global 
Partnership for Effective Development Cooperation. Others are focus on results, inclusive 
partnerships, and transparency, as well as mutual accountability (OECD, 2020).
Political commitment towards immunisation was made clear in 2017 when the African 
Heads of States endorsed the Addis Declaration on Immunisation (ADI) at the 28th African 
Union Summit. It is comprised of ten commitments (Text Box 3) whose aspiration is to reach 
every child with lifesaving vaccines and to ensure there is universal access to vaccinations 
in order to decrease child mortality (ADI, 2019). 
Text Box 3: Commitments of the 2017 Addis Declaration on Immunisation
2017 Addis Declaration on Immunisation Commitments
1.  Keep universal access to immunisation at the forefront of efforts to reduce child 
mortality.
2. Increase and sustain domestic investments and funding allocations for 
immunisation.
3.  Address persistent barriers in vaccine and healthcare delivery systems, especially in 
the poorest, most vulnerable and most marginalised communities.
4. Increase the effectiveness and efficiency of immunisation delivery systems as an 
integrated part of strong and sustainable primary healthcare systems.
5.  Attain and maintain high quality surveillance for targeted vaccine preventable 
diseases.
6.  Monitor progress towards achieving the goals of the global and regional 
immunisation plans.
7.  Ensure polio legacy transition plans are in place by end-2016.
8.  Develop a capacitated African research sector to enhance immunisation 
implementation and uptake.
9.  Build broad political will for universal access to life saving vaccines.
10. Promote and invest in regional capacity for the development and production of 
vaccines.
3.5.1 Immunisation financing
(Mihigo, Okeibunor, Anya, Mkanda, & Zawaira, 2017) posited that funding the commitment 
of national governments for immunisation is perhaps one of the most important challenges 
facing immunisation programmes in the WHO African Region. Whilst noting that a significant 
part of immunisation funding in the region comes from development partners − mainly Gavi 
the Vaccine Alliance6 − the report asserts that there is a dire need for a paradigm shift for 
governments to begin to take more responsibility for immunisation to ensure sustainable 
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funding. Similarly, Bangura et al.’s (2020) systematic review found that financial limitation 
was a major barrier that hinders childhood immunisation in SSA. They recommended that 
countries should increase government financial GDP allocation to their health sectors, 
consistent with the recommendation in the Abuja declaration7 (WHO, 2011) arguing that 
increased financial resources would enable countries to equip and upgrade existing health 
facilities and to increase their numbers. They hypothesised that targeted resources may 
motivate and enable staff deployed in remote areas for effective outreach activities to 
maximise coverage of immunisation. (Madhi & Rees, 2018) point to government political 
commitment as the key to securing local country ownership of the entire immunisation 
programme, reiterating earlier calls by (Machingaidze, Wiysonge, & Hussey, 2013) that 
demanded that African leaders must be held accountable for meeting agreed country 
targets and honouring international commitments made.
(Kamara, et al., 2008) reviewed financial sustainability plans (FSPs) from several low-income 
Gavi-supported countries including twenty-seven countries in the WHO African region, and 
found that, generally, country strategies fell in three categories: (1) mobilising additional 
resources, (2) increasing the reliability of resources, and (3) improving programme efficiency.
In mobilising additional resources, most SSA countries’ FSPs looked at advocacy for increased 
central government allocation, with some also looking into contributions from sub-national 
authorities, private sector sources, and a few considering sourcing from within communities 
for example through community insurance schemes. Notably, 21/27 countries planned to 
lobby for more donor funding with 10/27 targeting Gavi, the vaccine alliance (Kamara, et 
al., 2008).
In practice, in a bid to mobilise additional resources from central governments, countries 
have employed different innovations with varying success and progress. These include 
ring-fencing traditional vaccine budgets as well as enacting immunisation legislation, 
including a financing obligation from governments in countries such as Senegal, Uganda, 
Madagascar and Cameroon. However, as of 2016, no funds were actually flowing in any 
of these countries. In Ghana, which has broader earmarks for health, the Ministry of Health 
used a portion of the value-added tax revenues that fund the National Health Insurance 
Scheme to fund vaccine purchases to meet the country’s Gavi co-financing commitment 
in 2016. Global experience suggests that earmarking for health can be effective if health 
services are a high national priority, the purpose is broadly defined (such as for national 
health coverage), and there is some flexibility to reallocate from earmarked funds if other 
urgent priorities emerge. But the effectiveness of an earmark can diminish over time, with 
the budget rigidity it creates leading to inefficiencies (Kamara, et al., 2008)
According to (Kamara, et al., 2008) some countries have explored the option of establishing 
a trust fund, including Cameroon, Nigeria, Senegal, Kenya, Mali, the Republic of the Congo, 
Sierra Leone and Uganda. Inspiration has been taken from the Zimbabwe National AIDS Trust 
Fund that was set up in 1999 and which provides 50% of national spending for antiretroviral 
therapies, accounting for about 10% of Ministry of Health spending on HIV/AIDS. The fund 
raised US$2.6 billion between 2000 and 2006 and another US$26 million in 2011. The funding 
source is a 3% AIDS levy charged on incomes and profits in the formal sector. On the other 
hand, trust funds can be costly and challenging to manage, and much has yet to be learned 
about governance and managerial structures in relation to immunisation funding. Trust funds 
could use up more political capital than is justified by the pay-out, while not necessarily 
5 Gavi offers financial support to countries for 17 different vaccines, primarily new and underused vaccines, including 
pneumococcal conjugate and rotavirus vaccines. Gavi does not support ‘traditional’ vaccines, such as Bacille Calmette 
Guerin and oral polio vaccines. Countries receiving Gavi vaccine support are obliged to co-finance a fraction of the 
vaccine costs for routine immunisation by co-procuring a portion of vaccines (Henderson, Gouglas, & Craw 2016).
7 In April 2001, heads of state of African Union countries met and pledged to set a target of allocating at least 15% of their 
annual budget to improve the health sector. At the same time, they urged donor countries to “fulfil the yet to be met 
target of 0.7% of their GNP as official Development Assistance to developing countries.”
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meeting all of the funding needs for immunisation. The effectiveness of immunisation trust 
funds has not been extensively assessed as most countries are still in the early stages of the 
process (Kamara, et al., 2008). 
(Lydon P, et al., 2008) analysis showed evidence that the existence of a specific line in the 
national budget is associated with increased governmental budget allocations for vaccines 
and routine immunisation financing, and yet (Griffiths, et al., 2020) analysis of 33 African 
countries’ national budgets found only 19 of the 33 (58%) countries that were assessed as 
meeting the criteria of a budget line item for the purchase of vaccines, and only a few 
countries included line items for activities essential to vaccine delivery. Two countries had 
a budget line for cold chain (Niger and Zambia, 7%), five countries included vaccination 
campaigns (17%) and three countries had surveillance (CAR, Congo and Madagascar). 
Kenya, Nigeria, and Senegal have successfully sought to increase immunisation financing 
by conducting regular immunisation budget advocacy using economic evidence (Sabin 
Vaccine Institute, 2019). In addition to using evidence, engaging at a high level with both 
the Ministry of Health and Ministry of Finance was associated with positive outcomes (GAVI 
Alliance, 2007). (Petu, 2018) argued that having a comprehensive multi-year plan enables 
the Extended Programme on Immunisation(EPI) to go through a process that ensures priority-
setting, and, on the basis of that, argue for government budget allocation. This is because 
the process establishes a matching of resource with expected cost to determine gaps, and 
to the extent that costing and planning are fundamental, subsequent government funding 
based on the plans and cost will assure sustainability.
The ADI 2019 progress report shows (Figure 11) that as of 2018, six countries were 100% 
funding their immunisation programmes while 15 countries funded more than 50% of their 
programmes. In addition, 19 countries have increased their contribution for their immunisation 
programmes (ADI, 2019).
Regarding increasing the reliability of resources, (Kamara, et al., 2008) found that country 
FSPs cited strategies such as budgeting and financial management, negotiating for longer 
term commitments from donors, and decentralisation to quicken disbursements. Increasing 
reliability of funding helps to improve the predictability of resources from which to plan 
and implement immunisation activities. With more predictable resources, gaps in financing 
can be identified and steps taken to plan within constraints or to seek additional sources 
of funding. Experience from the Democratic Republic of the Congo showed that donor 
confidence is facilitated by a high absorption capacity of funds allocated, having a 
transparent accounting and budget management system, equitable distribution of funds to 
the subnational level, and government commitment demonstrated by increasing domestic 
investment over time (Le Gargasson, Breugelmans, Mibulumukini, Da Silva, & Colombini, 
2013). Decentralisation gives the programme greater ownership at the subnational level 
and can result in increased transparency and accountability as was demonstrated in 
Kenya, where local governments achieved improvements within 100 days by engaging 
front-line workers in the planning process and providing them with clear goals and intensive 
monitoring and feedback (McQuestion, et al., 2011).
 
On improving programme efficiency, country FSP strategies included management 
and planning, reduction of vaccine wastage, review of the rationale for new antigen 
introduction, cold chain maintenance, strengthening of vaccine procurement service 
delivery/coverage improvement, reduction of drop-out rates, improvement of social 
mobilisation, and integration with other programmes (Kamara et al. 2008). In order to get 
the most out of efficiency interventions, focus needs to be put on the biggest cost drivers. 
The (Brenzel, 2015) analysis of cost drivers for routine immunisation in Gavi-eligible countries 
found that among African countries, vaccines continued to be the major cost driver (51%) 
followed by immunisation-specific personnel costs (22%). Introduction of new vaccines had 
a significant impact on routine immunisation costs (3 new vaccine introductions increasing 
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costs by 141%), as did non-vaccine delivery costs/health system costs. One of the strategies 
employed for controlling vaccine price is pooled procurement, which yields lower prices for 
vaccines than those paid by individual countries on their own. UNICEF supply division provides 
a platform for pooled procurement for Gavi supported countries. African countries outside 
of Gavi support are also coming together to harness the benefits of pooled procurement 
(WHO, 2019). Experience has shown that although passive pooled procurement may have 
advantages, particularly better price and lower procurement transaction costs, its use 
creates risk of supplier exit and/or poor investment in capacity, which can lead to supply 
shortages and/or higher prices in the long term. A better approach is one of strategic 
pooled procurement, which includes elements to ensure supply sustainability and to better 
coordinate matching of supply and demand. This requires ensuring that the buying power 
and price reducing effects of pooled procurement do not shift market balances and 
endanger the health of the market (WDI, 2015).
 
Figure 11: WHO African countries’ percentage government contributions to their immunisation 
programs 2015-2018
Source: Addis Declaration on Immunisation Progress report, 2019 (ADI, 2019).
(Yip & Hafez, 2015) showed that countries have used policy reforms to improve health 
system efficiencies. Burundi instituted a system of performance-based financing explicitly 
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uptake of maternal and child health services. Ethiopia introduced a task-shifting policy 
from physicians to mid-level professionals and provided regional quotas for physicians 
from disadvantaged regions. Democratic Republic of the Congo introduced a single 
management and donor harmonisation policy to address health system challenges such as 
fragmentation of health financing and service delivery, high management costs, duplication 
and waste of resources and misallocation of resources. They introduced a single national 
steering committee, a common manual of procedures agreed upon by the government 
and all partners, single operational district plans, and a joint financial management 
system. Reduced fragmentation resulting from the reforms decreased the management 
costs of internationally funded projects from an average of 28% in 2005 to 9% in 2011. 
Between 2009 and 2014, better coordination resulted in savings of more than US$56 million. 
Greater transparency in planning and budgeting enabled some provinces to increase 
their operational budgets by 30%. Reform of the pharmaceutical sector and pooling of 
resources for drug transport by the regional distribution centres of the National System for 
Procurement of Essential Medicines resulted in annual savings of more than US$3.5 million. 
The funds thus released were used to pay the remaining staff, increasing their motivation 
and productivity. Kenya conducted an analysis of its public health care expenditure and 
found that increasing allocative efficiency, which is the mix of services or interventions that 
maximises health improvements, both within disease entities (such as prevention through 
immunisation versus behavioural change strategies combined with treatment) and across 
them (i.e.: how the health of a population can be most improved with existing resources), 
and found cost savings and funds reallocated (World Bank Group, 2014).
3.5.2 Community ownership
(Mihigo, Okeibunor, Anya, Mkanda, & Zawaira, 2017) fronted community ownership of the 
immunisation programmes as a means to create sustainable demand for immunisation 
services, particularly for increasing demand for and uptake of available services through 
social and behavioural change interventions. There intervention would ensure government 
transparency and accountability, support resource mobilisation, influence national health 
policies, and support the monitoring and evaluation of effective programmes. 
A key interlocutor facilitating both communities and governments to fulfil their mandates 
in the immunisation landscape are CSOs. CSOs utilise their unique capacity to forge 
connections between communities, health services, and the governments responsible 
to those communities. At the Ministerial Conference on Immunisation in Africa, held in 
Addis Ababa, Ethiopia in 2016, over 80 organisations endorsed the CSOs’ declaration on 
immunisation to show their commitment to their role in holding governments accountable 
to improve vaccine access and coverage in Africa in line with the Global Vaccine Action 
Plan and other supportive roles as outlined in Civil Society Declaration for Equitable Access 
to Immunisation in Africa (WHO Ethiopia, 2016), (WHO Africa, 2017). In this declaration, CSOs 
outlined the ways in which they can support governments and communities, Text Box 4.
Text Box 4: Civil Society Declaration for Equitable Access to Immunisation in Africa 2016
Civil Society Declaration for Equitable Access to Immunisation in Africa: CSO 
Commitments (2016)
1. Support government efforts in delivering vaccination, ensuring that these services 
reach communities in hard-to-reach locations and marginalised communities. 
2. Support efforts to increase the acceptability and uptake of vaccines in these 
communities through demand creation activities. 
3. Deliver immunisation services in emergency and crisis contexts where appropriate.
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4. Assist governments to improve the performance and management of the systems 
that deliver vaccination. 
5. Participate in the elaboration, implementation, and monitoring of health and 
immunisation policies.
6. Hold governments accountable to deliver the immunisation services needed by 
their entire populations, especially the poorest and most marginalised members of 
society.
7. Raise the voice of communities by supporting and empowering them to participate 
in immunisation processes and accountability mechanisms. 
8. Hold donor country governments and multilateral institutions accountable to fulfil 
the pledges they have made to deliver funding and support for immunisation and 
ensure this is aligned with national health plans and priorities
(Catholic Relief Services, 2019) provided documentation of CSO activities in SSA that showed 
that they have made significant contributions towards increasing immunisation uptake in 
the region. Examples cited in areas of operation include: 
1) Coordination and surveillance:
a) In Ethiopia health extension workers were facilitated to train community volunteers 
in surveillance and recording, resulting in 71,904 children who had defaulted on 
their immunisation schedule within their first year being identified and put back on 
schedule. 
b) The Cross Border Initiative in the Horn of Africa had community volunteers trained in 
surveillance methods to work with mobile border communities conducting advocacy 
and sensitisation activities.
c) In Sierra Leone, CSOs conducted a knowledge, attitudes and practices survey that 
showed that 30% of children had missed a scheduled vaccination due to fear of 
contacting Ebola virus. A social behaviour change campaign was conducted to 
restore confidence in the health system in general and the immunisation programme 
in particular.
d) In South Sudan, CSOs conducted independent monitoring of immunisation campaigns 
resulting in improved speed on providing data to stakeholders and adding an extra 
layer of credibility to the data.
e) In Zambia, Churches Health Association of Zambia’s HPV Project was developed to 
complement the Government of Zambia’s efforts to reach out to caregivers of girls 
aged 9 – 11 in the districts of Lusaka. They trained community volunteers to conduct 
door-to-door campaigns, drama skits, radio engagements, and school parent-
teacher engagement. This resulted in 94% of eligible girls in Lusaka districts being 
vaccinated.
2) Social behaviour change: 
a) A CSO in Nigeria, targeting male Muslim heads of families, enlisted the support of 
Muslim leaders in vaccine-hesitant communities to disseminate information on the 
importance of immunisation to male household leaders during Iftah prayers at the 
breaking of the fast each day. In 2017, the Strategy resulted in more than 90% of 
children from non-compliant households receiving vaccinations. 
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b) In Togo and Madagascar, CSOs used father role models to raise immunisation 
awareness serving as champions and role models in their communities, while women 
immunisation champions were used in Guinea to address myths about infertility 
among vaccinated Wahabi women, resulting in nearly 100 children from hesitant 
families being vaccinated against polio.
3) Stronger community level systems and services: 
a) In Zambia, CSOs were involved in taking immunisation to hard-to-reach areas by 
encouraging local institutions like schools to serve as mobile outreach service points on 
pre-determined days and encouraging the health care works to provide integrated 
services during outreach to include topics of interest such as nutrition. 
b) In Uganda, CSOs partnered with local health authorities to introduce the use of 
community-owned child registers as an efficient tracking system for finding unimmunised 
children and those who had missed follow-up doses, as well as to improve the consistency 
of immunisation data between health facilities.
4) Advocacy: 
a) In 2013, the Malawi Health Equity Network conducted budget allocation and used 
research findings as evidence to advocate with national-level stakeholders, including 
parliamentarians, for increased budget allocation towards immunisation efforts. The 
outcome was a 1% increase for health care, approximately a $17 million boost, including 
$2.1 million earmarked specifically for immunisation in the 2014-15 budget. 
b) In Madagascar, a CSO involved the local community to improve immunisation service 
delivery at health centres and to foster community confidence. They did this by engaging 
locals in drafting a set of nine articles explaining how the health centre should be run 
and what local people could expect from it. These articles were based on the people’s 
right to health, which is enshrined in national legislation.
3.5.3 Enabling environment
Socio-political environment has been observed to significantly impact the feasibility 
of implementing immunisation programmes. This is mostly evident in armed conflicts, 
humanitarian emergencies, and disease pandemics.
3.5.3.1	Armed	conflicts,	humanitarian	emergencies,	and	immunisation
Political violence has been fundamental to Africa’s post-colonial political history. Although 
large-scale organised political violence is on the decline and large areas are stabilising, 
in the post-2000 era, armed conflict in SSA has been characterised by contemporary 
insurgencies targeting civilians and fighting on the periphery of fairly well consolidated 
states, as in Senegal, Nigeria, Angola, Namibia, Mali, Sudan, and Uganda. Also on the rise 
are election related violence and territorial fights for natural resources. Geo-political shifts 
are the likely cause of declines and changes in war patterns in the region (Straus, 2012).
(Sato, 2019) analysed the linkage between armed conflict and immunisation and found 
a large negative effect of conflict events on the likelihood of vaccination. If an armed 
conflict occurs within 10 km of where a child resides, the odds that child will receive any 
vaccination are 47.2% lower. Children that are affected by conflict suffer disproportionately 
from Vaccine Preventable Disease (VPD) outbreaks. For instance, out of about 3,400 cases 
of polio reported globally between 2010 and 2016, 70% were in conflict-affected countries. 
As a result of conflict, an outbreak of polio in the refugee camps along the Kenya-Somalia 
border in 2013 later spread into the surrounding communities. Similarly, in Somalia, low 
vaccination coverage caused by the conflict in 2010 and 2011 led to a massive measles 
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outbreak, and the number of cases increased from 145 to 1562 cases per million children 
under 5 years. The arrival of refugees from Somalia into the Dadaab refugee camp in Kenya 
and the Dollo Ado refugee camp in Ethiopia in 2010 and 2011 led to a devastating measles 
outbreak (Ngo, et al., 2020). (Grundy & Biggs, 2019) similarly found that low immunisation 
coverage and VPD outbreaks are of major concern in conflict-affected countries, especially 
in the sub-regions most affected by conflict. They asserted that the concentration of poor 
immunisation coverage and disease outbreaks in conflict-displaced populations reinforces 
the notion that there is an intertwining of political and health security agendas. Their study 
showed that conflict affects immunisation in several ways, including human resources 
availability, retention, competency, and distribution. 
 
(Ngo, et al., 2020) reported that in Cote D’Ivoire − a country that has been divided between 
the rebel-held north and the government-controlled south − many HCW have fled the north. 
Conflict also leads to the destruction of health-care facilities, disruption of vaccine cold 
chain management, crippling of the healthcare system, killing of health-care personnel, 
obstruction of humanitarian access, poor hygiene and nutritional status, and displacement 
of people internally, into the bushes and across borders. 
In Cameroon, attacks on medical facilities and health workers were recorded in the conflict 
in the northwest and southwest regions of the country. Sixty-three hospitals were deliberately 
attacked or occupied by fighting groups; ambulances were destroyed, patients or victims 
taken away, and summarily executed, health workers were threatened, abducted, 
subjected to violence, or killed. By 2020, over sixty-one attacks on health-care facilities and 
thirty-nine against medical professionals had been documented.
While effective delivery of immunisation services to populations in these settings may be 
fraught with varied levels of risk, experiences in several geographical settings indicate that, 
with a good understanding of the nuances of the conflict and a great deal of operational 
flexibility, reaching and immunising eligible populations in these settings may continue to be 
operationally viable (Nnandi, et al., 2017).
Most countries describe a mix of strategies for service delivery in conflict-affected areas 
including campaign and outreach services, supported by civil society partnerships and 
volunteer networks that are tailored to local security conditions. Lessons from Nigeria and 
Somalia illustrate effective operational tactics such as: negotiating secure physical access, 
engaging local communities, collaboration with military or other security personnel, and 
coordinating humanitarian aid deliveries, transit or cross-border vaccination strategy (Ngo, 
et al., 2020). Other tactics successfully employed in the polio eradication strategy include 
use of geographic information systems technology to assess population sizes and locations 
in conflict zones, and flexibility around vaccine scheduling and dosing options. Advocacy 
with local traditional and religious leaders, information sharing with communities, training of 
local residents as vaccinators, and building community mobilisation networks with support 
from community “gatekeepers” may help shed light on the felt needs of the communities 
and build trust between the community and the programme (Nnandi, et al., 2017).
In Somalia, negotiated cessation of conflicts between armed parties allowed physical 
access to populations in conflict settings, with a number of vaccination rounds and polio 
surveillance conducted during the ensuing period. In northern Nigeria, the Volunteer 
Community Mobiliser programme − a focused initiative that recruits and trains local 
community women as social mobilisers and vaccination workers − is considered to have 
bolstered participation in house-to-house polio and other routine immunisation programs, 
especially in security-compromised and hard-to-reach communities.
In the Central African Republic, use of ‘low-tech’ vaccination systems have been successfully 
used. Vaccines are being mainly stored in kerosene fridges to maintain the cold chain, and 
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healthcare workers travel by foot, on bicycles, or in wooden canoes to reach the children 
in the furthest parts of the country for home visits to deliver vaccines, which they carry in 
cooler boxes (UNICEF Connect, 2015).
Prioritising flexibility around age and other eligibility criteria for receiving the vaccines is a 
key strategy used in conflict-affected Borno and Yobe states of Nigeria. Additionally, in the 
face of potential supply shortages, the use of fractional-dose vaccines in these settings may 
be key to improving coverage  (Nnandi, et al., 2017). Opportunistic vaccination during days 
of tranquillity, establishing barrier vaccination zones, strengthening vaccination activities 
at transit and border-crossing sites, and vaccinating at camps for refugees and internally 
displaced persons and other sites of mass gathering through “hit and run,” has been used 
during conflicts in the Democratic Republic of the Congo, Southern Sudan, Angola, and 
Nigeria. (Peyraud, et al., 2018) report that in a chronic humanitarian emergency in the Central 
African Republic, preventive multi-antigen vaccination campaigns resulted in a substantial 
and rapid increase in vaccine coverage after three vaccination rounds. Conversely, 
(Nnandi, et al., 2017) reported that public trepidation and reluctance to use health services 
delivered by foreign agencies presented as a common barrier accounting for lower-than 
expected coverage of some interventions. In the Lake Chad region, efforts have been 
made to integrate nutritional assessments and interventions with polio vaccination (Nnandi, 
et al., 2017) .
Beside armed conflict, there are other humanitarian emergency-spurring events that result 
in mass population movements, such as: sudden deterioration of nutritional status, natural or 
industrial disasters, and/or sudden breakdown of critical administrative and management 
functions. These events result in large-scale disruption of public health and related services 
(WHO, 2017)
Migrant communities are more susceptible to challenges of accessing vaccination 
services associated with health policies, organisation of health systems, legal and financial 
restrictions (Rechel, et al., 2011).  (Antai, 2011) conducted a quantitative study in Nigeria 
to assess the individual and community level explanatory factors related to low childhood 
vaccinations rates in migrants and non-migrants. Due to migrant mothers likely to give birth 
at home as opposed to a hospital to avoid confrontation regarding legal documentation, 
the study found vaccination coverage to be low for children whose mothers did not receive 
prenatal care and those who were delivered at home. Some of the foregoing strategies for 
immunisation of displaced populations − such as border crossing vaccination, prioritising 
flexibility around age and other eligibility criteria, vaccination at refugee camps, and mass 
campaigns − are applicable in these cases as well (WHO, 2017).
(Meteke, et al., 2020), in their systematic review on delivering infectious disease interventions 
to women and children in conflict settings, identified a gap where strategies focus on those 
who manage to reach refugee camps during conflicts with less attention to those in the 
bushes and those who escape into other cities or countries unrecorded. Their study identified 
an urgent need for the expansion of vaccination coverage during conflicts to include non-
camp populations. They also emphasised the need for health actors to educate those 
around them while maintaining the perception of their impartiality and neutrality.
3.5.3.2 Immunisation in pandemic situations
Disease pandemics disrupt health service provision and can lead to a decline in immunisation 
coverage as evidenced in Liberia and Guinea where, due to an Ebola outbreak, there was 
a sharp decline of more than 25% in the monthly number of children vaccinated against 
measles in 2014 and 2015 as compared to the previous years (Masresha B. G., et al., 2020). 
Even after the outbreak and conducting of mass immunisation campaigns, immunisation 
coverage figures continued to decline or stagnate (Delamou, et al., 2017). 
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In the case of the 2020 COVID-19 global pandemic, the indirect costs of the pandemic, 
related to the measures implemented to deal with the spread of the virus, such as lockdowns 
and social distancing were predicted to negatively impact immunisation coverage in Africa 
due to its weak health systems and shown to have resulted in a 50–80% drop in vaccination in 
2020 compared to the previous year in rural Sierra Leone, despite continued service delivery 
operations at health facilities (Adamu, Jalo, Habonimana, & Wiysonge, 2020) (Danilo, 
Bianca, Ngaima, & Francesco, 2020). A modelling study by (Abbas, et al., 2020) found that 
the deaths prevented by sustaining routine childhood immunisation in Africa outweigh the 
excess risk of COVID-19 deaths associated with vaccination clinic visits, especially for the 
vaccinated children. 
The justified need to continue with routine immunisation during the pandemic has called for 
development of standard operating procedures to minimise risk of COVID-19 transmission 
during routine immunisation visits. WHO issued guidelines that called for the maintenance 
of immunisation services while keeping the following in mind: local mandates for physical 
distancing and health system context, the local burden of VPDs, and the status and 
anticipated status of local COVID-19 transmission.Where health system capacity was 
intact and essential health services operational (for example adequate human resources, 
adequate vaccine supply), WHO recommended that fixed site immunisation services and 
VPD surveillance should be executed, while maintaining physical distancing measures and 
appropriate infection control precautions (WHO, 2020b).
NITAGs were considered critical in contextualising the global WHO recommendations, and 
the NITAGs in South Africa and Zimbabwe issued guidance documents for short- and medium-
term country implementation (NITAG Resource Center, 2020). (Adamu, Jalo, Habonimana, 
& Wiysonge, 2020) using a causal loop approach, demonstrated the multifaceted impact 
of increased COVID-19 infections on immunisation in Africa, showing that there would be 
a decrease in the number of health workers that would be available to provide routine 
immunisation services as they would be redeployed to COVID-19-related tasks. Similarly, 
it would decrease available health facilities, as hospital and clinics would be converted 
to COVID-19 treatment and isolation centres. In addition, immunisation funding would 
reduce, as funds were diverted to the COVID-19 response. All of these would contribute 
to a decrease in the availability of immunisation services. The study thus recommends the 
use of systems thinking and implementation science concepts to support immunisation 
system redesign to adjust to the pressures of COVID-19 by accelerating the uptake and 
utilisation of multifaceted evidence-based strategies in policy and practice. Examples cited 
include use of personal protective equipment to protect health workers from infection; 
ensuring critical consideration of context in COVID-19-related policies, such as a special 
transportation scheme to improve the mobility of health workers; and permitting caregivers 
seeking immunisation services to use identifiers, such as child health cards at roadblocks 
during lockdown (Adamu, I., Habonimana, & Wiysonge, 2020).
Pandemics and epidemics are also driving the invention and development of new vaccines 
at much faster rates, increasing hesitancy because of the dangers − whether real or 
perceived − of a fast-tracked vaccine. (Bunch, 2021).
3.5.4 Conclusions on Political Ownership
1. The immunisation programme in SSA is still largely dependent on external funding for 
its operations, putting the programme in a risky and unsustainable position. While there 
has been an overall positive trend in national government commitments in taking on 
greater ownership for immunisation financing, translating this into practice has not been 
uniformly realised. Of particular concern is financing for newly introduced vaccines, that 
have been observed as the biggest cost driver for incremental immunisation financing 
needs in the region.
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2. Civil Society Organisations are key interlocutors in facilitating ownership at the national 
level by holding governments accountable to their mandates, and at the community 
level by fostering participatory inclusion and accountability of sub-national governments 
and the populace.
3. SSA has been historically vulnerable to disruptive environmental forces such as political 
and civil unrest, natural disasters, and disease outbreaks resulting in armed conflicts, mass 
population movements, flooding, droughts, famines, and humanitarian emergencies. 
These negative environmental events are disruptive to the region’s fragile health systems 
and especially to the highly sensitive immunisation programme, putting the region at a 
risk of vaccine-preventable disease outbreaks and loss of immunisation gains already 
made.
3.5.5 Recommendations on political ownership
4. National governments, being held accountable by regional bodies and national 
institutions such as the African Union and National Parliaments, should act upon 
financing commitments made in the Addis Declaration on Immunisation to gradually 
and impactfully increase their budgetary allocations to immunisation and provide the 
requisite oversight to the transparent and equitable use of funds provided. 
5. National and sub-national immunisation programme managers, with the support of Civil 
Society Organisations, should provide the enabling financing advocacy and decision 
support frameworks required by decision-makers. They can do this by developing and 
making available clear and timely planning, budgeting, and accounting documents; 
making use of standard tools such as country multi-year plans that outline the country’s 
contextual priorities; as well as demonstrating value for money invested in the immunisation 
programme. 
6. National political leaders should be cognisant of the inevitable intertwining of political 
and health security agendas and should thus ensure peaceful and secure communities 
through application of democratic principles of governance and equitable share of 
national resources. This will minimise incidents of conflict, which have significant negative 
impacts on the immunisation programme. In cases of humanitarian emergencies, lessons 
learned from the region to ensure continued vaccination of children should be applied.
7. The Africa Centres for Disease Control and Prevention should provide evidence-based 
technical tools and measures that can be adapted to ensure that the contextual 
dynamics in individual African countries are taken into account in all disease pandemic 
mitigation responses in order to minimise adverse effects on healthcare programmes 
including immunisation.
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3.6 Overarching conclusions and recommendations
SSA is predominated by countries categorised as low-income, a rapidly growing popu-
lation with low levels of education, a significant burden of displaced persons, and a 
weak healthcare system. Still, some recognisable progress has been made thanks to the 
concerted efforts of immunisation stakeholders ranging from technical staff at all levels of 
government, researchers, civil society organisations, and development partners. Based 
on the region’s demographic challenges, it comes as no surprise that the root causes of 
low coverage and under-immunisation are summarised under deficiencies in knowledge, 
shortage of trust, and difficulties in accessing reliable immunisation services. The identified 
strategies to address these challenges (including increasing access to accurate information, 
building trust, and removing barriers to accessing reliable immunisation services) centre on 
national political commitment and ownership of the immunisation programme. Whilst the 
study identified some significant shortages in empirical research evidence, particularly in 
the area of effectiveness of strategies deployed to respond to identified root causes for low 
coverage and under-immunisation in SSA, the lack of such evidence should not be used 
as a defence for inaction. Where contextualised anecdotal evidence exists, this should 
continue to inform decision makers as researchers conduct more systematic studies that will 
inform scaling initiatives.
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ANNEXURES
Annex 1: List of committee members with short biographies 
1.	 Prof	Shabir	Madhi	(South	Africa),	Co-chair
 Prof Madhi is Professor of Vaccinology at the University of the Witwatersrand, the Director 
of the South African Medical Research Council’s (SAMRC) Respiratory and Meningeal 
Pathogens Research Unit (RMPRU), Chairperson of the South African National Adviso-
ry Group on Immunisation (NAGI) and member of SAGE (since 2019). He is the former 
Executive Director of the National Institute for Communicable Diseases (NICD). He is a 
Member of the Academy of Science of South Africa (MASSAf).
2.	 Prof	Harriet	Mayanja-Kizza	(Uganda),	Co-Chair	
 Prof Mayanja-Kizza is the Dean of the School of Medicine at Makerere University, Ugan-
da and an Honorary Lecturer at Case Western Reserve University, Cleveland, Ohio, USA. 
(Adjunct appointment). She is a World Health Organisation Advisor in TB and HIV immu-
nopathogenesis. Prof Harriet Mayanja-Kizza is a Fellow of Uganda National Academy of 
Sciences.
3. Prof Richard Adegbola (Nigeria) 
 Prof Adegbola is a Consultant and a Research Professor at the Department of Microbiol-
ogy at the Nigerian Institute of Medical Research, Lagos, Nigeria. He previously worked 
for GlaxoSmithKline Vaccines as Global Director, Scientific Affairs & Public Health and 
for the Bill & Melinda Gates Foundation, USA. He was a member of the WHO’s Meningi-
tis Vaccine Project Advisory Group. He is a Fellow of the Nigerian Academy of Science 
(FAS). 
4. Dr Juliet Kiguli (Uganda)
 Dr Kiguli is a Senior Lecturer, at the Department of Community Health and Behavioral 
Sciences at the College of Health Sciences, Makerere University, Uganda. She is an an-
thropologist and gender analyst, teaching and carrying out community-based research 
and is also a consultant on several bilateral and multilateral projects in gender, culture 
and health. Her work explores major debates in gender, power and cultural modernity, 
policy, social theory, contemporary anthropology and health. 
5. Dr Annet Kisakye (Uganda)
 Dr Kisakye is the EPI team leader at the WHO Uganda office, and she is also the WHO 
liaison representative on the Uganda National Immunisation Technical Advisory Group 
(UNITAG). She also provides technical support to the Ministry of Heath/UNEPI and pro-
vides management, supervision and coordination within the WHO country office immu-
nisation unit, including external counterparts from the unit at IST, AFRO, HQ and MOH.
6. Prof Sileshi Lulseged Desta (Ethiopia) 
 Prof Lulseged is Professor of Paediatrics and Child Health at Addis Ababa University and 
Senior Associate Research Scientist at Columbia University’s Mailman School of Public 
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Health, New York, USA. He is also Senior Advisor at ICAP Columbia University Program in 
Ethiopia. He has previously served as Head of the Department of Paediatrics and Child 
Health and Director of Clinical Epidemiology Service at Addis Ababa University. 
7. Dr Helene Mambu-Ma-Disu (Democratic Republic of Congo)
 Dr Helene Mambu-Ma-Disu is currently a Senior Programme Officer for the Sustainable 
Immunisation Financing Programme of the Sabin Vaccine Institute, for whom she co-
ordinates field activities in Democratic Republic of the Congo, Republic of the Congo 
and Madagascar. She served as a Regional Adviser for the African regional office of the 
WHO and was a WHO Resident Representative in several countries in the region, before 
retiring in 2008. 
8. Prof Jeffrey Mphahlele (South Africa)
 Prof Mphahlele is the Vice-President of the South African Medical Research Council 
(SAMRC). He is also the former Head of the Department of Virology, former co-director 
of the SAMRC’s Diarrhoeal Pathogens Research Unit and co-founder of the South Afri-
can Vaccination and Immunisation Centre (SAVIC) at Sefako Makgatho Health Scienc-
es University. He is a member of the National Advisory Group on Immunisation (NAGI) as 
well as Member of the Academy of Science of South Africa (MASSAf).
9. Ms Diana Kizza Mugenzi (Uganda) 
 Ms Diana Kizza Mugenzi is a Senior Programme Manager for the Sustainable Health Fi-
nancing Programme at the Clinton Health Access Initiative (CHAI). Currently, she coor-
dinates and provides strategic oversight for the CHAI SIDA-funded project for the identi-
fication and implementation of more cost-effective approaches to universal healthcare 
delivery at all tiers of eSwatini’s health system. She previously worked as an ODI Fellow 
with the Rwanda Ministry of Health.
10. Prof Helen Rees (South Africa)
 Prof Rees is the founder and Executive Director of the Wits Reproductive Health and HIV 
Institute (WRHI), South Africa. She is an ad hominem Professor of Obstetrics and Gynae-
cology at the University of Witwatersrand, South Africa and an Honorary Professor at 
the London School of Hygiene and Tropical Medicine. She is a former chair of the WHO 
Strategic Advisory Group of Experts on Immunisation. She is a Member of the Academy 
of Science of South Africa (MASSAf).  
11. Prof Charles Shey Wiysonge (Cameroon and South Africa)
 Prof Charles Shey Wiysonge is the Director of the South African Cochrane Centre at the 
SAMRC and a Professor at both Stellenbosch University and the University of Cape Town 
in South Africa. He is a former member of the WHO Strategic Advisory Group of Experts 
on Immunisation and the Gavi Independent Review Committee. He is a member of the 
WHO Measuring Behavioural and Social Drivers of Vaccination Working Group and a 
Member of the Academy of Science of South Africa (MASSAf).
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Annex	2:	Symposium	Programme	(South	Africa,	30-31	July	2018)
Root Causes of Low Coverage and Under-Immunisation in 
sub-Saharan Africa
HOSTED	BY:	ASSAf	at	Crowne	Plaza	Hotel,	Johannesburg,	South	Africa
DAY ONE: 30 JULY 2018
09:00 – 10:00 Registration with tea/coffee 
Session One: Opening Session and Setting the Scene
Facilitator: Professor Helen Rees - Wits Reproductive Health and HIV Institute & WHO Re-
gional Immunisation Technical Advisory Group
10:00 – 10:15
Opening and Welcome Remarks 
Prof Himla Soodyall, General Secretary: Academy of Science of South 
Africa Council 
Mr Christian Acemah, Executive Secretary: Uganda National Academy 
of Sciences (UNAS)
10:15 – 10:30
Purpose of the Symposium and the Consensus Study
Prof Shabir Madhi (South Africa), Prof Harriet Mayanja-Kizza 
(Uganda), Study Co-Chairs
10:30 – 11:00
Keynote: Country Ownership of Immunisation in Southern Africa
Dr Nonhlanhla Dlamini, Chief Director: Child & Youth, National Depart-
ment of Health (South Africa)
11:00 – 11:30 Interactive Question and Answer Session
11:30 – 12:00 HEALTH BREAK
12:00 – 12:30 Keynote:	Vaccine	Strategies,	Policies	&	Access	to	Immunisation	in	
sub-Saharan Africa
Dr Richard Mihigo, Regional Advisor: Immunisation and Vaccine Devel-
opment Programme, World Health Organisation AFRO Region
12:30 – 13:00 Interactive Question and Answer Session
13:00 – 14:00 LUNCH
Session Two: Challenges to Vaccine Delivery and Immunisation Coverage
Facilitator:	Dr	Annet	Kisakye,	World	Health	Organisation
Presentations (20 minutes per speaker)
14:00 – 14:20 United Nations Children’s Fund (UNICEF)Dr Mariame Sylla, Chief for Health and Nutrition: UNICEF (South Africa)
14:20 – 14:40 WHO Regional Immunisation Technical Advisory Group (RITAG)Prof Helen Rees, Chair: WHO RITAG 
14:40 – 15:00 Immunisation Implementation ResearchProf Charles Shey Wiysonge, Director: Cochrane South Africa 
15:00 – 15:30 Discussion
15:30 – 15:50 HEALTH BREAK
15:50 – 16:10
Creating an Enabling Legal Environment for Immunisation through the 
Uganda Immunisation Law




Dr Joan Awunyo-Akaba, Executive Director: Future Generations Interna-
tional (Ghana)




Prof Rose Burnett, Sefako Makgatho Health Sciences University (South 
Africa)
16:50 – 17:20 Discussion
17:20 – 17:30 WRAP-UP	&	CLOSURE	FOR	DAY	ONE
DAY TWO: 31 JULY 2018
09:00 – 09:30 Arrival tea/coffee
Session Three: Effective Interventions and Opportunities
Facilitators:	Professor	Shabir	Madhi	&	Professor	Harriet	Mayanja-Kizza
Presentations (20 minutes per speaker)
09:30 – 09:50 
Poverty and Inequity (including rural vs urban disparities and displaced 
communities)
Mr Thulani Matsebula,Senior Health Economist: World Bank (South Afri-
ca)
09:50 – 10:00 Discussion 
10:00 – 11:00
Key Effective Interventions
1. Health Information Systems 
    Dr Vincent Shaw, Executive Director: Health Information Systems 
Programme (Namibia & South Africa)
2. Business Engagement
    Mr Neren Rau, Director for External Affairs, Public Policy & 
Communications: Merck Sharp and Dohme (South Africa)
3. African Vaccine Production 
    Dr Morena Makhoana, Chief Executive Officer: Biovac Institute (South 
Africa)
11:00 – 11:50 Discussion
11:50 – 12:20 BREAK
12:20 – 12:40
Role of the Media and Communications
Ms Mia Malan, Executive Director: Mail and Guardian’s Bhekisisa (South 
Africa)
12:40 – 13:20 Overarching	Facilitated	Discussion	&	Wrap-up
13:20 – 13:30 Closing	Remarks:	ASSAf	&	UNAS
13:30 -15:00 LUNCH	&	DEPARTURE	
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Annex	3:	Symposium	Programme	(Uganda,	27-28	February	2019)
DAY ONE: 27 February 2019
08:00 – 09:00 Arrival and Registration 
Session One - Opening and Setting the Scene
Moderator:	Sarah	Kiguli,	Fellow,	Uganda	National	Academy	of	Sciences	(Uganda)
09:00 – 09:15
Opening and Welcome Remarks 
Nelson Sewankambo, President, Uganda National Academy of Scienc-
es (UNAS)
Himla Soodyall, Executive Officer: Academy of Science of South Africa 
(ASSAf) 
09:15 – 09:30 Purpose of the Symposium and the Consensus StudyHarriet Mayanja-Kizza (Uganda), Study Co-Chair
09:30 – 10:00 Keynote Address: Owning our Immunisation SystemsJane Ruth Aceng, Minister of Health, Uganda
10:00 – 10:30 Interactive Question and Answer Session
10:30 – 11:00 HEALTH BREAK
11:00 – 11:30 Keynote Address: End of Decade of Vaccines; Which way Africa?Hon Huda Oleru WHO/SAGE DoV Working Group Expert Member  
11:30 – 12:00  Interactive Question and Answer Session
12:00 – 12:30  
Keynote Address: Civil Society Organisations in Immunisation 
Systems
Emmanuel Mugisha, Country Director, PATH Uganda Office
12:30 – 13:00 Interactive Question and Answer Session
13:00 – 14:00 LUNCH
Session Two: Drivers of Success in Vaccine Delivery
Moderator:	Grace	Ndeezi,	Fellow,	Uganda	National	Academy	of	Sciences	(Uganda)
Presentations (20 minutes per speaker)
14:00 – 14:20 
Lessons	from	Development	Partners,	United	Nations	Children’s	Fund	
(UNICEF)
Viorica Berdaga, Chief of Health, UNICEF Uganda
14:20 – 14:40 Lessons from West AfricaIssa Ouedraogo, EPI Manager, Burkina Faso
14:40 – 15:00 Lessons from Southern AfricaJoan Marembo, EPI Manager, Zimbabwe 
15:00 – 15:30 Interactive Discussion
15:30 – 16:00 HEALTH BREAK
Session Three: Challenges in Immunisation Systems in Different Economic Conditions
Moderator:	Diana	Kizza	Mugenzi,	Clinton	Health	Access	Initiative	(Kingdom	of	Eswatini)
16:00 – 16:20 View from UgandaAlfred Driwale, EPI Manager, Uganda
16:20 – 16:40 Interactive Discussion
16:40 – 17:00 WRAP UP FOR DAY ONE
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DAY TWO: 28 February 2019
09:00 – 09:00 Arrival and Registration
Session	Four:	Vaccines	Industry,	Leveraging	Lessons	Learned	for	Sustained	Success
Moderator:	Annet	Kisakye,	World	Health	Organization	Uganda
Presentations (20 minutes per speaker)
09:00 – 09:20 Developing the National Vaccine IndustryOyewale Tomori, Chairman, Biovaccines, Nigeria
09:20 – 09:40
The Global Vaccine Industry in Sub-Saharan Africa
Nekoye Otsyula, GSK, Medical Manager - Vaccines, Kenya and East 
Africa
09:40 – 10:00 Discussion
Session Five: Stakeholder’s Talking Point– Creating Solutions Together
Moderator:	Jeffrey	Mphahlele,	Medical	Research	Council	(South	Africa)
10:00 – 10:30 BREAK
10:30 – 12:00
Presentations	(20	Mins	per	Speaker,	with	10	mins	Q	and	A)
Health Workers in Immunisation
Ombeva Malande, Director East African Center for Vaccines and Im-
munisation (Kenya)
Immunisation Hesitant Communities
Alima Essoh, Director, Agence Medicine Preventive AMP (Cote d’Ivoire)
12:00– 12:30 Overarching	Facilitated	Discussion	&	Wrap-upHarriet Mayanja-Kizza (Uganda), Study Co-Chair
12:30 – 13:00
Closing Remarks
Himla Soodyall, Executive Officer: Academy of Science of South Africa 
(ASSAf)
Nelson Sewankambo, President: Uganda National Academy of Scienc-
es (UNAS)
13:00 -14:00 LUNCH	&	DEPARTURE
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